200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 130209-82-4

130209-82-4

130209-82-4 | 5-Heptenoic acid, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-, 1-methylethyl ester, (5Z)-

CAS No: 130209-82-4 Catalog No: AG000U58 MDL No:MFCD00216074

Product Description

Catalog Number:
AG000U58
Chemical Name:
5-Heptenoic acid, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-, 1-methylethyl ester, (5Z)-
CAS Number:
130209-82-4
Molecular Formula:
C26H40O5
Molecular Weight:
432.5928
MDL Number:
MFCD00216074
IUPAC Name:
propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoate
InChI:
InChI=1S/C26H40O5/c1-19(2)31-26(30)13-9-4-3-8-12-22-23(25(29)18-24(22)28)17-16-21(27)15-14-20-10-6-5-7-11-20/h3,5-8,10-11,19,21-25,27-29H,4,9,12-18H2,1-2H3/b8-3-/t21-,22+,23+,24-,25+/m0/s1
InChI Key:
GGXICVAJURFBLW-CEYXHVGTSA-N
SMILES:
O[C@@H](CCc1ccccc1)CC[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)OC(C)C)O
UNII:
6Z5B6HVF6O

Properties

Complexity:
526  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
5  
Defined Bond Stereocenter Count:
1  
Exact Mass:
432.288g/mol
Formal Charge:
0
Heavy Atom Count:
31  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0
Molecular Weight:
432.601g/mol
Monoisotopic Mass:
432.288g/mol
Rotatable Bond Count:
14  
Topological Polar Surface Area:
87A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
4.3  

Literature

Title Journal
Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study. The British journal of ophthalmology 20170601
Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis. Chemical research in toxicology 20150518
IOP-Lowering Effect of ONO-9054, A Novel Dual Agonist of Prostanoid EP3 and FP Receptors, in Monkeys. Investigative ophthalmology & visual science 20150401
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology 20131101
Investigation of surfactants suitable for stabilizing of latanoprost. International journal of pharmaceutics 20121015
Intraocular pressure-lowering effect of 0.005% latanoprost with two different dosing regimens. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20121001
A comparative study of a preservative-free latanoprost cationic emulsion (Catioprost) and a BAK-preserved latanoprost solution in animal models. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20121001
Corneal epithelial cell viability following exposure to ophthalmic solutions containing preservatives and/or antihypertensive agents. Advances in therapy 20121001
Long-term medical management of primary open-angle glaucoma and ocular hypertension in the UK: optimizing cost-effectiveness and clinic resources by minimizing therapy switches. Journal of glaucoma 20120901
Amino acid provides shortcut to drugs. Nature 20120816
Comparison of dorzolamide/timolol and latanoprost/timolol fixed combinations on diurnal intraocular pressure control in primary open-angle glaucoma. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20120801
Efficacy of single glaucoma medication in combined latanoprost and timolol XE therapy in patients with open-angle glaucoma and ocular hypertension: a discontinuation study. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20120801
Effects of long-term topical anti-glaucoma medications on meibomian glands. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20120801
Efficacy and safety of switching to travoprost/timolol fixed-combination therapy from latanoprost monotherapy. Japanese journal of ophthalmology 20120701
Comparison of efficacy of four prostaglandin analogues by bilateral treatment in healthy subjects. Japanese journal of ophthalmology 20120701
Lack of association between polymorphisms in the prostaglandin F2α receptor and solute carrier organic anion transporter family 2A1 genes and intraocular pressure response to prostaglandin analogs. Ophthalmic genetics 20120601
Efficacy of single glaucoma drug in combined timolol XE, latanoprost and brinzolamide therapy: a discontinuation study. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20120601
Diurnal and nocturnal variations in aqueous humor dynamics of patients with ocular hypertension undergoing medical therapy. Archives of ophthalmology (Chicago, Ill. : 1960) 20120601
A study of initial therapy for glaucoma in southern India: India Glaucoma Outcomes and Treatment (INGOT) Study. Ophthalmic epidemiology 20120601
Microbead-induced ocular hypertensive mouse model for screening and testing of aqueous production suppressants for glaucoma. Investigative ophthalmology & visual science 20120601
Ophthalmic generics--are they really the same? Ophthalmology 20120601
A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia. Journal of the American Academy of Dermatology 20120501
Fixed-combination brimonidine-timolol versus latanoprost in glaucoma and ocular hypertension: a 12-week, randomized, comparison study. Current medical research and opinion 20120501
[The rabbit's IOP values after instillation of the L-arginine HCL with selected antiglaucomatic drugs mixtures prepared in vitro. (comparative study of results of the experimental works)]. Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti 20120501
In vitro study of antiadipogenic profile of latanoprost, travoprost, bimatoprost, and tafluprost in human orbital preadiopocytes. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20120401
Comparison of human ocular distribution of bimatoprost and latanoprost. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20120401
A review of the use of latanoprost for glaucoma since its launch. Expert opinion on pharmacotherapy 20120401
Latanoprost versus timolol as first choice therapy in patients with ocular hypertension. A cost-effectiveness analysis. Acta ophthalmologica 20120301
Effects of an unfixed combination of latanoprost and pilocarpine on the intraocular pressure and pupil size of normal dogs. Veterinary ophthalmology 20120301
Topical application of 0.005% latanoprost increases episcleral venous pressure in normal dogs. Veterinary ophthalmology 20120301
Ocular hypotensive effect of tafluprost in latanoprost low-responder cynomolgus monkeys. Journal of glaucoma 20120201
Impact of eyelid closure on the intraocular pressure lowering effect of prostaglandins: a randomised controlled trial. The British journal of ophthalmology 20120201
A comparison of active ingredients and preservatives between brand name and generic topical glaucoma medications using liquid chromatography-tandem mass spectrometry. Current eye research 20120201
The long-term outcomes of four alternative treatment strategies for primary open-angle glaucoma. Acta ophthalmologica 20120201
The efficacy of a monocular drug trial in normal-tension glaucoma. Korean journal of ophthalmology : KJO 20120201
The influence of central corneal thickness on response to topical prostaglandin analogue therapy. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20120201
Long-term effect of BAK-free travoprost on ocular surface and intraocular pressure in glaucoma patients after transition from latanoprost. Journal of glaucoma 20120101
Bilateral upper eyelid retraction caused by topical bimatoprost therapy. Ophthalmic plastic and reconstructive surgery 20120101
Periocular changes following long-term administration of latanoprost 0.005%. Ophthalmic plastic and reconstructive surgery 20120101
Randomized crossover study of latanoprost and travoprost in eyes with open-angle glaucoma. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20120101
Topical prostaglandin fixed combinations in UK primary care: observational study using data from the health improvement network. European journal of ophthalmology 20120101
Effect of ketorolac add-on treatment on intra-ocular pressure in glaucoma patients receiving prostaglandin analogues. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 20120101
Prostaglandin-timolol fixed combinations efficacy: myth or reality? European journal of ophthalmology 20120101
Efficacy and tolerability of prostaglandin-timolol fixed combinations: a meta-analysis of randomized clinical trials. European journal of ophthalmology 20120101
Latanoprost 0.005% test formulation is as effective as Xalatan® in patients with ocular hypertension and primary open-angle glaucoma. European journal of ophthalmology 20120101
Association of Cogan-Reese syndrome, exfoliation syndrome, and secondary open-angle glaucoma. European journal of ophthalmology 20120101
Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye. International journal of nanomedicine 20120101
Reduced in vivo ocular surface toxicity with polyquad-preserved travoprost versus benzalkonium-preserved travoprost or latanoprost ophthalmic solutions. Ophthalmic research 20120101
The preservative polyquaternium-1 increases cytoxicity and NF-kappaB linked inflammation in human corneal epithelial cells. Molecular vision 20120101
A prospective study evaluating IOP changes after switching from a therapy with prostaglandin eye drops containing preservatives to nonpreserved tafluprost in glaucoma patients. TheScientificWorldJournal 20120101
A 4-week, dose-ranging study comparing the efficacy, safety and tolerability of latanoprost 75, 100 and 125 μg/mL to latanoprost 50 μg/mL (xalatan) in the treatment of primary open-angle glaucoma and ocular hypertension. BMC ophthalmology 20120101
Prostanoid receptors involved in regulation of the beating rate of neonatal rat cardiomyocytes. PloS one 20120101
Repigmentation of hair after latanoprost therapy. Journal of the European Academy of Dermatology and Venereology : JEADV 20111201
Indirect sympatholytic actions at β-adrenoceptors account for the ocular hypotensive actions of cannabinoid receptor agonists. The Journal of pharmacology and experimental therapeutics 20111201
Ocular hypotensive effects and safety over 3 months of switching from an unfixed combination to latanoprost 0.005%/timolol maleate 0.5% fixed combination. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20111201
Central serous chorioretinopathy associated with topical latanoprost therapy. Ocular immunology and inflammation 20111201
Evaluation of investigator bias in industry-funded clinical trials of latanoprost. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20111201
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). PLoS computational biology 20111201
Lack of evidence for a link between latanoprost use and malignant melanoma: an analysis of safety databases and a review of the literature. The British journal of ophthalmology 20111101
Incidence of deepening of the upper eyelid sulcus after switching from latanoprost to bimatoprost. Japanese journal of ophthalmology 20111101
Comparative in vitro toxicology study of travoprost polyquad-preserved, travoprost BAK-preserved, and latanoprost BAK-preserved ophthalmic solutions on human conjunctival epithelial cells. Current eye research 20111101
Development and validation of a liquid chromatography/electrospray ionization tandem mass spectrometry method for the quantification of latanoprost free acid in rabbit aqueous humor and ciliary body. Journal of mass spectrometry : JMS 20111101
Twenty-four-hour intraocular pressure control with latanoprost-timolol-fixed combination versus bimatoprost in patients who switched from timolol. Journal of glaucoma 20111001
Effects of glaucoma medications and preservatives on cultured human trabecular meshwork and non-pigmented ciliary epithelial cell lines. The British journal of ophthalmology 20111001
Asymmetry of 24-hour intraocular pressure reduction by topical ocular hypotensive medications in fellow eyes. Ophthalmology 20111001
Comparison of latanoprost and timolol in pediatric glaucoma: a phase 3, 12-week, randomized, double-masked multicenter study. Ophthalmology 20111001
Do prostaglandin analogs affect eyelid position and motility? Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20111001
Latanoprost systemic exposure in pediatric and adult patients with glaucoma: a phase 1, open-label study. Ophthalmology 20111001
Efficacy and safety of switching from topical latanoprost to bimatoprost in patients with normal-tension glaucoma. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20111001
Long-term outcomes of prostaglandin analog versus timolol maleate in ocular hypertensive or primary open-angle glaucoma patients in Europe. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20111001
A case hypersensitive to bimatoprost and dexamethasone. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20111001
A dual acting compound with latanoprost amide and nitric oxide releasing properties, shows ocular hypotensive effects in rabbits and dogs. Experimental eye research 20110901
Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating prostaglandin F2α agonist, in preclinical models. Experimental eye research 20110901
Latanoprost therapy after sunken eyes caused by travoprost or bimatoprost. Optometry and vision science : official publication of the American Academy of Optometry 20110901
Improved prediction of fellow-eye response in one-eye trials using multiple intraocular pressure measurements. Japanese journal of ophthalmology 20110901
A phase 2, randomized, dose-response trial of taprenepag isopropyl (PF-04217329) versus latanoprost 0.005% in open-angle glaucoma and ocular hypertension. Current eye research 20110901
Cost-offset analysis: bimatoprost versus other prostaglandin analogues in open-angle glaucoma. The American journal of managed care 20110901
The effect of prostaglandin analogues on central corneal thickness of patients with chronic open-angle glaucoma: a 2-year study on 129 eyes. Acta ophthalmologica 20110801
Spectrofluorometry assays for oxidative stress and apoptosis, with cell viability on the same microplates: a multiparametric analysis and quality control. Toxicology in vitro : an international journal published in association with BIBRA 20110801
The comparison of the effects of latanoprost, travoprost, and bimatoprost on central corneal thickness. Cornea 20110801
The intraocular pressure reducing effect of brinzolamide as adjunctive therapy to latanoprost. Current medical research and opinion 20110801
Response to case study on darkening of a facial skin graft after latanoprost. Archives of ophthalmology (Chicago, Ill. : 1960) 20110701
Effect of latanoprost on choroidal blood flow regulation in healthy subjects. Investigative ophthalmology & visual science 20110622
In vitro comparative toxicology of polyquad-preserved and benzalkonium chloride-preserved travoprost/timolol fixed combination and latanoprost/timolol fixed combination. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20110601
The stabilization mechanism of latanoprost. International journal of pharmaceutics 20110530
Alterations in anterior chamber depth in primary open-angle glaucoma patients during latanoprost therapy. Acta ophthalmologica 20110501
Latanoprost promotes neurite outgrowth in differentiated RGC-5 cells via the PI3K-Akt-mTOR signaling pathway. Cellular and molecular neurobiology 20110501
Polyquad-preserved travoprost/timolol, benzalkonium chloride (BAK)-preserved travoprost/timolol, and latanoprost/timolol in fixed combinations: a rabbit ocular surface study. Advances in therapy 20110401
Effect of topical 0.03% flurbiprofen and 0.005% latanoprost, alone and in combination, on normal canine eyes. Veterinary ophthalmology 20110301
[Comparison of primary medicament therapy effects and primary argon laser trabeculoplasty on regulation of intraocular pressure and stability of perimetry findings in open angle glaucoma]. Vojnosanitetski pregled 20110301
24-Hour intraocular pressure control between travoprost/timolol fixed combination, latanoprost/ timolol fixed combination and standard timolol in primary open angle glaucoma and ocular hypertension. Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20110301
Assessment of aqueous humor dynamics in the mouse by a novel method of constant-flow infusion. Investigative ophthalmology & visual science 20110203
Long-term effect of latanoprost on central corneal thickness in normal tension glaucoma. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20110201
Thermal stability of bimatoprost, latanoprost, and travoprost under simulated daily use. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20110201
[Comparison of intraocular pressure reducing effects of three prostaglandin eyedrops in open-angle glaucoma]. [Zhonghua yan ke za zhi] Chinese journal of ophthalmology 20110201
The impact of intraocular pressure reduction on retinal ganglion cell function measured using pattern electroretinogram in eyes receiving latanoprost 0.005% versus placebo. Vision research 20110128
Five-year, multicenter safety study of fixed-combination latanoprost/timolol (Xalacom) for open-angle glaucoma and ocular hypertension. Journal of glaucoma 20110101
A correlation between latanoprost-induced conjunctival hyperemia and intraocular pressure-lowering effect. Journal of glaucoma 20110101
The influence of topical diclofenac sodium on the ocular hypotensive effect of latanoprost in glaucoma patients. Journal of glaucoma 20110101
An Indian perspective on primary angle closure and glaucoma. Indian journal of ophthalmology 20110101
The clinical impact of 2 different strategies for initiating therapy in patients with ocular hypertension. Journal of glaucoma 20110101
Changes to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprost. Japanese journal of ophthalmology 20110101
Effectiveness of ophthalmic solution preservatives: a comparison of latanoprost with 0.02% benzalkonium chloride and travoprost with the sofZia preservative system. BMC ophthalmology 20110101
[In vitro evaluation for corneal damages by anti-glaucoma combination eye drops using human corneal epithelial cell (HCE-T)]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20110101
A multicenter, retrospective chart review study comparing index therapy change rates in open-angle glaucoma or ocular hypertension patients newly treated with latanoprost or travoprost-Z monotherapy. BMC ophthalmology 20110101
Incidence of new coding for dry eye and ocular infection in open-angle glaucoma and ocular hypertension patients treated with prostaglandin analogs: retrospective analysis of three medical/pharmacy claims databases. BMC ophthalmology 20110101
Effects of benzalkonium chloride- or polyquad-preserved fixed combination glaucoma medications on human trabecular meshwork cells. Molecular vision 20110101
Persistence with prostaglandin agonist use with and without adjunctive therapy for glaucoma patients: a Canadian population-based analysis. The patient 20110101
Comparative efficacy and safety of the fixed versus unfixed combination of latanoprost and timolol in Chinese patients with open-angle glaucoma or ocular hypertension. BMC ophthalmology 20110101
[Assessment of visual function under treatment with topical antiglaucoma agents and systemic vasodilators. Clinical study on glaucoma patients]. Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20110101
Sustained release of an anti-glaucoma drug: demonstration of efficacy of a liposomal formulation in the rabbit eye. PloS one 20110101
Therapeutic potential of new hydrogen sulfide-releasing hybrids. Expert review of clinical pharmacology 20110101
[The latest developments in glaucoma therapy using fixed combination products]. Oftalmologia (Bucharest, Romania : 1990) 20110101
[Fixed combination of topical prostaglandin analogue in glaucoma treatment]. Oftalmologia (Bucharest, Romania : 1990) 20110101
[Results of the IOP decrease after application of some mixtures of amino acids and antiglaucomatics in rabbits (a review of experimental publications)]. Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti 20110101
Heart block following topical latanoprost treatment. BMJ case reports 20110101
Effects of prostaglandin F(2α) analogues on endothelin-1-induced impairment of rabbit ocular blood flow: comparison among tafluprost, travoprost, and latanoprost. Experimental eye research 20101201
Hyperemia reduction after administration of a fixed combination of bimatoprost and timolol maleate to patients on prostaglandin or prostamide monotherapy. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20101201
The role of benzalkonium chloride in the occurrence of punctate keratitis: a meta-analysis of randomized, controlled clinical trials. The Annals of pharmacotherapy 20101201
[Clinical trial of the generic product UNILAT following its efficiency and safety in glaucoma and intraocular hypertension]. Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti 20101201
Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells. Advances in therapy 20101101
Comparative study of three prostaglandin analogues in the treatment of newly diagnosed cases of ocular hypertension, open-angle and normal tension glaucoma. Clinical & experimental ophthalmology 20101001
24-h Intraocular pressure control with evening-dosed travoprost/timolol, compared with latanoprost/timolol, fixed combinations in exfoliative glaucoma. Eye (London, England) 20101001
Comparison of Travoprost and Bimatoprost plus timolol fixed combinations in open-angle glaucoma patients previously treated with latanoprost plus timolol fixed combination. American journal of ophthalmology 20101001
Effectiveness of dorzolamide–timolol (COSOPT) in patients who were treatment naive for open-angle glaucoma or ocular hypertension: the COSOPT first-line study. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20101001
Prostaglandin efficacy and safety study undertaken by race (the PRESSURE study). Journal of glaucoma 20100901
Surface tension of aqueous humor. Journal of glaucoma 20100901
Comparison of the effects of dorzolamide/timolol and latanoprost/timolol fixed combinations upon intraocular pressure and progression of visual field damage in primary open-angle glaucoma. Current medical research and opinion 20100901
Duration of anesthesia affects intraocular pressure, but not outflow facility in mice. Current eye research 20100901
Effects of topical administration of latanoprost, timolol, or a combination of latanoprost and timolol on intraocular pressure, pupil size, and heart rate in clinically normal dogs. American journal of veterinary research 20100901
Efficacy and mechanisms of intraocular pressure reduction with latanoprost and timolol in participants with ocular hypertension: a comparison of 1 and 6 weeks of treatment. Journal of glaucoma 20100801
Eyelash preservation during chemotherapy and topical prostaglandin therapy. Archives of internal medicine 20100726
Efficacy and safety of fixed combinations of latanoprost/timolol and dorzolamide/timolol in open-angle glaucoma or ocular hypertension. Eye (London, England) 20100701
Twenty-four-hour ocular hypotensive effects of 0.0015% tafluprost and 0.005% latanoprost in healthy subjects. Japanese journal of ophthalmology 20100701
Serious spinal sequelae following the use of eye drops. Eye (London, England) 20100601
In vitro toxicity of topical ocular prostaglandin analogs and preservatives on corneal epithelial cells. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20100601
A review of preserved and preservative-free prostaglandin analogues for the treatment of open-angle glaucoma and ocular hypertension. Drugs of today (Barcelona, Spain : 1998) 20100601
Ocular surface tolerability of prostaglandin analogs in patients with glaucoma or ocular hypertension. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20100601
Macular oedema linked to latanoprost and rosiglitazone. Prescrire international 20100601
The prostaglandin transporter OATP2A1 is expressed in human ocular tissues and transports the antiglaucoma prostanoid latanoprost. Investigative ophthalmology & visual science 20100501
Absence of corneal endothelium injury in non-human primates treated with and without ophthalmologic drugs and exposed to 2.8 GHz pulsed microwaves. Bioelectromagnetics 20100501
Monocular drug trial. Ophthalmology 20100501
Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication. Acta ophthalmologica 20100501
The combination latanoprost-timolol versus twice daily 0.50% timolol administration either associated or not with latanoprost: efficacy and tolerability in the primary open-angle glaucoma. European review for medical and pharmacological sciences 20100501
Reaction of Müller cells in an experimental rat model of increased intraocular pressure following timolol, latanoprost and brimonidine. Brain research bulletin 20100429
Latanoprost in the treatment of eyelash alopecia in alopecia areata universalis. Journal of the European Academy of Dermatology and Venereology : JEADV 20100401
Physicians' treatment decisions, patient persistence, and interruptions in the continuous use of prostaglandin therapy in glaucoma. Current medical research and opinion 20100401
A model-based meta-analysis of the effect of latanoprost chronotherapy on the circadian intraocular pressure of patients with glaucoma or ocular hypertension. Clinical pharmacology and therapeutics 20100401
Effects of repeated administrations of tafluprost, latanoprost, and travoprost on optic nerve head blood flow in conscious normal rabbits. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20100401
Use of rituximab for periocular and intraocular mucosa-associated lymphoid tissue lymphoma. Ocular immunology and inflammation 20100401
Effect of latanoprost on the expression of matrix metalloproteinases and tissue inhibitor of metalloproteinase 1 on the ocular surface. Archives of ophthalmology (Chicago, Ill. : 1960) 20100401
Applanation tonometry versus dynamic contour tonometry in eyes treated with latanoprost. Journal of glaucoma 20100301
Treatment of glaucoma in clinical practice: four-year results from a patient registry in France. Journal of glaucoma 20100301
[Atypical unilateral glaucoma in a young patient]. Journal francais d'ophtalmologie 20100301
Latanoprost-induced changes in the iris and trabeculum: an electron-microscopic morphological study. International ophthalmology 20100201
Experimental model of ocular hypertension in the rat: study of the optic nerve capillaries and action of hypotensive drugs. Investigative ophthalmology & visual science 20100201
A randomized, 36-month, post-marketing efficacy and tolerability study in Sweden and Finland of latanoprost versus non-prostaglandin therapy in patients with glaucoma or ocular hypertension. Acta ophthalmologica 20100201
Fixed combination of latanoprost and timolol vs individual components for primary open-angle glaucoma or ocular hypertension: a randomized, double-masked study. Archives of ophthalmology (Chicago, Ill. : 1960) 20100201
A phase II study on the duration and stability of the intraocular pressure-lowering effect and tolerability of Tafluprost compared with latanoprost. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20100201
Efficacy and safety of tafluprost 0.0015% versus latanoprost 0.005% eye drops in open-angle glaucoma and ocular hypertension: 24-month results of a randomized, double-masked phase III study. Acta ophthalmologica 20100201
Skin pigmentation after NB-UVB and three analogues of prostaglandin F(2alpha) in guinea pigs: a comparative study. Journal of the European Academy of Dermatology and Venereology : JEADV 20100101
Using diurnal intraocular pressure fluctuation to assess the efficacy of fixed-combination latanoprost/timolol versus latanoprost or timolol monotherapy. The British journal of ophthalmology 20100101
ACS67, a hydrogen sulfide-releasing derivative of latanoprost acid, attenuates retinal ischemia and oxidative stress to RGC-5 cells in culture. Investigative ophthalmology & visual science 20100101
Efficacy and tolerability of bimatoprost versus travoprost in patients previously on latanoprost: a 3-month, randomised, masked-evaluator, multicentre study. The British journal of ophthalmology 20100101
Additive intraocular pressure reduction effect of fixed combination of maleate timolol 0.5%/dorzolamide 2% (Cosopt) on monotherapy with latanoprost (Xalatan) in patients with elevated intraocular pressure: a prospective, 4-week, open-label, randomized, controlled clinical trial. Journal of glaucoma 20100101
Does the fixed combination of bimatoprost/timolol really produce a better benefit/risk balance than the fixed combination of latanoprost/timolol? European journal of ophthalmology 20100101
A 12-week, randomized, double-masked study of fixed combination latanoprost/timolol versus latanoprost or timolol monotherapy. European journal of ophthalmology 20100101
Comparison of corneal wound healing rates after instillation of commercially available latanoprost and travoprost in rat debrided corneal epithelium. Journal of oleo science 20100101
VAV2 and VAV3 as candidate disease genes for spontaneous glaucoma in mice and humans. PloS one 20100101
Effect of three treatment protocols on acute ocular hypertension after phacoemulsification and aspiration of cataracts in dogs. Veterinary ophthalmology 20100101
Effects of switching to SofZia-preserved travoprost in patients who presented with superficial punctate keratopathy while under treatment with latanoprost. Japanese journal of ophthalmology 20100101
First-line latanoprost therapy in ocular hypertension or open-angle glaucoma patients: a 3-month efficacy analysis stratified by initial intraocular pressure. BMC ophthalmology 20100101
Persistence on prostaglandin ocular hypotensive therapy: an assessment using medication possession and days covered on therapy. BMC ophthalmology 20100101
Predictors of additional intraocular pressure reduction in patients changed to latanoprost/timolol fixed combination. BMC ophthalmology 20100101
Impact of once daily versus twice daily application of adjunctive timolol on the intraocular pressure-lowering effect of latanoprost. Ophthalmic research 20100101
Bilateral and simultaneous cystoid macular edema associated with latanoprost use: report of two cases. Arquivos brasileiros de oftalmologia 20100101
Long-term effect of latanoprost/timolol fixed combination in patients with glaucoma or ocular hypertension: a prospective, observational, noninterventional study. BMC ophthalmology 20100101
[Monotherapy with lipid structural derivatives in glaucoma]. Oftalmologia (Bucharest, Romania : 1990) 20100101
Development and validation of analytical procedure--control of residual 2-iodopropane in latanoprost. Acta poloniae pharmaceutica 20100101
Topical prostaglandin analogues do not affect selective laser trabeculoplasty outcomes. Eye (London, England) 20091201
Cost effectiveness of latanoprost and timolol maleate for the treatment of glaucoma in Scandinavia and the United Kingdom using a decision-analytic health economic model. Eye (London, England) 20091201
Latanoprost in pediatric glaucoma--pediatric exposure over a decade. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 20091201
Interaction of ocular hypotensive agents (PGF2 alpha analogs-bimatoprost, latanoprost, and travoprost) with MDR efflux pumps on the rabbit cornea. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20091201
Hyperemia-associated costs of medication changes in glaucoma patients treated initially with prostaglandin analogs. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20091201
Transient monocular visual loss following administration of topical latanoprost: a case report. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20091201
An unusual anatomical colocalization of alopecia areata and vitiligo in a child, and improvement during treatment with topical prostaglandin E2. Clinical and experimental dermatology 20091201
Changes in optic nerve head blood flow induced by the combined therapy of latanoprost and beta blockers. Acta ophthalmologica 20091101
Effect of bimatoprost, latanoprost, and unoprostone on matrix metalloproteinases and their inhibitors in human ciliary body smooth muscle cells. Investigative ophthalmology & visual science 20091101
Heightened cough sensitivity secondary to latanoprost. Chest 20091101
Effects of timolol and latanoprost on respiratory and cardiovascular status in elderly patients with glaucoma. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20091001
Intraocular pressure (IOP) reduction by latanoprost in Japanese normal tension glaucoma patients over a five-year period stratified by presenting IOP. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20091001
A comparison of bimatoprost 0.03% versus the fixed-combination of latanoprost 0.005% and timolol 0.5% in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label trial. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20091001
Comparison of the protective effects of prostaglandin analogues in the ischemia and reperfusion model of rabbit eyes. Experimental animals 20091001
Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs. Ophthalmology 20090901
Cystoid macular oedema within 24 h after a single application of latanoprost. International ophthalmology 20090801
Pneumatic trabeculoplasty vs latanoprost as adjunctive therapy to timolol in primary open-angle glaucoma or ocular hypertension. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20090801
Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response. American journal of ophthalmology 20090801
Assessing the efficacy of latanoprost vs timolol using an alternate efficacy parameter: the intervisit intraocular pressure range. American journal of ophthalmology 20090801
Effects of latanoprost in iris bioidentification. Acta ophthalmologica 20090801
Comment on Efficacy and tolerability of prostaglandin analogs. Journal of glaucoma 20090801
Switching from concomitant latanoprost 0.005% and timolol 0.5% to a fixed combination of travoprost 0.004%/timolol 0.5% in patients with primary open-angle glaucoma and ocular hypertension: a 6-month, multicenter, cohort study. Expert opinion on pharmacotherapy 20090801
Smoothing the intraocular pressure roller coaster: a new goal? American journal of ophthalmology 20090801
Traumatic interface oedema two years after LASIK. Clinical & experimental optometry 20090701
Meta-analysis of medical intervention for normal tension glaucoma. Ophthalmology 20090701
A Prospective, randomized, investigator-masked evaluation of the monocular trial in ocular hypertension or open-angle glaucoma. Ophthalmology 20090701
Corneal thickness and glaucoma medications. Ophthalmology 20090701
Relative efficacy of prostaglandins. Ophthalmology 20090701
Efficacy and safety of latanoprost in eyes with uveitic glaucoma. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20090601
A randomised crossover study comparing bimatoprost and latanoprost in subjects with primary angle closure glaucoma. The British journal of ophthalmology 20090601
Decreased intraocular pressure in mice following either pharmacological or genetic inhibition of ROCK. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20090601
Expression and functional evidence of the prostaglandin F2alpha receptor mediating contraction in human umbilical vein. European journal of pharmacology 20090521
Effects of prostanoid EP agonists on mouse intraocular pressure. Investigative ophthalmology & visual science 20090501
24-hour intraocular pressure and blood pressure levels with latanoprost/timolol fixed combination versus timolol. Current eye research 20090501
Bimatoprost/timolol fixed combination vs latanoprost/timolol fixed combination in open-angle glaucoma patients. Eye (London, England) 20090401
Intraocular pressure control and fluctuation: the effect of treatment with selective laser trabeculoplasty. The British journal of ophthalmology 20090401
An in vivo confocal microscopy analysis of effects of topical antiglaucoma therapy with preservative on corneal innervation and morphology. American journal of ophthalmology 20090401
First-year treatment patterns among new initiators of topical prostaglandin analogs. Current medical research and opinion 20090401
The impact of ocular adverse effects in patients treated with topical prostaglandin analogs: changes in prescription patterns and patient persistence. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20090401
Intraocular pressure control among patients transitioned from latanoprost to travoprost at a Veterans Affairs Medical Center Eye Clinic. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20090401
Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata. Journal of the American Academy of Dermatology 20090401
Expression of multidrug resistance associated protein 5 (MRP5) on cornea and its role in drug efflux. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20090401
[Development of conjunctival hyperemia with the use of a fixed combination of latanoprost/timolol: systematic review and meta-analysis of clinical trials]. Archivos de la Sociedad Espanola de Oftalmologia 20090401
New prostaglandin derivative for glaucoma treatment. Bioorganic & medicinal chemistry letters 20090315
A rare complication from prostaglandin analogue therapy. Clinical & experimental optometry 20090301
Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trials. The British journal of ophthalmology 20090301
Latanoprost protects rat retinal ganglion cells from apoptosis in vitro and in vivo. Experimental eye research 20090301
Comparing diurnal and nocturnal effects of brinzolamide and timolol on intraocular pressure in patients receiving latanoprost monotherapy. Ophthalmology 20090301
Immunohistochemical expression of HLA-DR in the conjunctiva of patients under topical prostaglandin analogs treatment. Journal of glaucoma 20090301
The effect of latanoprost on ocular blood flow. International ophthalmology 20090201
Effect of latanoprost and timolol on the histopathology of the human conjunctiva. The British journal of ophthalmology 20090201
Prostaglandin subtype-selective and non-selective IOP-lowering comparison in monkeys. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20090201
The effect of prostaglandin analogs and prostamide on central corneal thickness. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20090201
Efficacy and tolerability of latanoprost compared to dorzolamide combined with timolol in the treatment of patients with elevated intraocular pressure: a meta-analysis of randomized, controlled trials. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20090201
Cost-effectiveness of latanoprost and timolol maleate for the treatment of glaucoma in Scandinavia and the United Kingdom, using a decision-analytic health economic model. Eye (London, England) 20090101
Discrepancy between results and abstract conclusions in industry- vs nonindustry-funded studies comparing topical prostaglandins. American journal of ophthalmology 20090101
Efficacy of the fixed combinations of bimatoprost or latanoprost plus timolol in patients uncontrolled with prostaglandin monotherapy: a multicenter, randomized, investigator-masked, clinical study. European journal of ophthalmology 20090101
Cost effectiveness of travoprost versus a fixed combination of latanoprost/timolol in patients with ocular hypertension or glaucoma: analysis based on the UK general practitioner research database. Clinical drug investigation 20090101
[Melanoma during latanoprost therapy: three cases]. Annales de dermatologie et de venereologie 20090101
Bimatoprost/timolol: a review of its use in glaucoma and ocular hypertension. Drugs & aging 20090101
[Efficacy of latanoprost versus travoprost assessed by daily intraocular pressure curve]. Arquivos brasileiros de oftalmologia 20090101
PGF(2alpha) FP receptor contributes to brain damage following transient focal brain ischemia. Neurotoxicity research 20090101
Incidence of hyperemia associated with bimatoprost treatment in naïve subjects and in subjects previously treated with latanoprost. European journal of ophthalmology 20090101
Systematic review of intraocular pressure-lowering effects of adjunctive medications added to latanoprost. Ophthalmic research 20090101
Efficiency of travoprost versus fixed-combination latanoprost/timolol. Clinical drug investigation 20090101
The efficacy of latanoprost in the treatment of alopecia areata of eyelashes and eyebrows. European journal of dermatology : EJD 20090101
Evaluation of the cytotoxic effects of ophthalmic solutions containing benzalkonium chloride on corneal epithelium using an organotypic 3-D model. BMC ophthalmology 20090101
Long-term effects of prostaglandin analogues on the anterior chamber depth of patients with primary open-angle glaucoma. Cutaneous and ocular toxicology 20090101
Aerobic exercise and intraocular pressure in normotensive and glaucoma patients. BMC ophthalmology 20090101
[Receptors involved in the mechanism of action of topical prostaglandines]. Oftalmologia (Bucharest, Romania : 1990) 20090101
Comparison of the ocular tolerability of a latanoprost cationic emulsion versus conventional formulations of prostaglandins: an in vivo toxicity assay. Molecular vision 20090101
Visual function, optic nerve structure, and ocular blood flow parameters after 1 year of glaucoma treatment with fixed combinations. European journal of ophthalmology 20090101
Efficacy and safety of bimatoprost as replacement for latanoprost in patients with glaucoma or ocular hypertension: a uniocular switch study. Journal of glaucoma 20090101
Study of the effects of ocular hypotensive drugs on number of neurons in the retinal ganglion layer in a rat experimental glaucoma. European journal of ophthalmology 20090101
Xal-Ease: impact of an ocular hypotensive delivery device on ease of eyedrop administration, patient compliance, and satisfaction. European journal of ophthalmology 20090101
Extensive facial skin pigmentation after latanoprost treatment. Cutaneous and ocular toxicology 20090101
[Bimatoprost therapy in glaucoma]. Oftalmologia (Bucharest, Romania : 1990) 20090101
Efficacy of latanoprost in management of chronic angle closure glaucoma. Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH 20090101
Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension. Acta ophthalmologica 20081201
Anterior uveitis associated with fixed-combination latanoprost and timolol. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20081201
Herpetic keratitis in a patient who used two different prostaglandin analogue ophthalmic solutions: a case report. Puerto Rico health sciences journal 20081201
Long-term effects of latanoprost monotherapy on intraocular pressure in Japanese glaucoma patients. Journal of glaucoma 20081201
Efficacy and tolerability of prostaglandin analogs: a meta-analysis of randomized controlled clinical trials. Journal of glaucoma 20081201
Second-line therapy with dorzolamide/timolol or latanoprost/timolol fixed combination versus adding dorzolamide/timolol fixed combination to latanoprost monotherapy. The British journal of ophthalmology 20081101
Comparison of morning versus evening dosing and 24-h post-dose efficacy of travoprost compared with latanoprost in patients with open-angle glaucoma . Current medical research and opinion 20081101
Effects of oxidative stress in trabecular meshwork cells are reduced by prostaglandin analogues. Investigative ophthalmology & visual science 20081101
Serous retinal detachment in the macula related to latanoprost use. International ophthalmology 20081001
Effects of the timolol-dorzolamide fixed combination and latanoprost on circadian diastolic ocular perfusion pressure in glaucoma. Investigative ophthalmology & visual science 20081001
Side effects of commonly used glaucoma medications: comparison of tolerability, chance of discontinuation, and patient satisfaction. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20081001
Changes in intraocular pressure following a switch from latanoprost monotherapy to latanoprost/timolol fixed combination therapy in patients with primary open-angle glaucoma or ocular hypertension: results from a clinical practice database. Current medical research and opinion 20081001
Long-term IOP lowering with bimatoprost in open-angle glaucoma patients poorly responsive to latanoprost. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20081001
Short-term effects of topical tafluprost on retinal blood flow in cats. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20081001
[Cost-efficacy analysis of fixed combinations of prostaglandin/prostamide for treating glaucoma]. Archivos de la Sociedad Espanola de Oftalmologia 20081001
Estimation of ocular rigidity based on measurement of pulse amplitude using pneumotonometry and fundus pulse using laser interferometry in glaucoma. Investigative ophthalmology & visual science 20080901
A comparison of long-term intraocular pressure fluctuation in patients treated with bimatoprost or latanoprost. American journal of ophthalmology 20080901
Twenty-four-hour intraocular pressure and blood pressure levels with bimatoprost versus latanoprost in patients with normal-tension glaucoma. The British journal of ophthalmology 20080901
Conjunctival and corneal reactions in rabbits following short- and repeated exposure to preservative-free tafluprost, commercially available latanoprost and 0.02% benzalkonium chloride. The British journal of ophthalmology 20080901
A comparison of dorzolamide/timolol-fixed combination versus bimatoprost in patients with open-angle glaucoma who are poorly controlled on latanoprost. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20080801
Latanoprost-induced changes in rat intraocular pressure: direct or indirect? Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20080801
Quantitative analysis of conjunctival goblet cells after chronic application of topical drops. Advances in therapy 20080801
Morpho-functional follow-up of the optic nerve in treated ocular hypertension: disc morphometry and steady-state pattern electroretinogram. Current eye research 20080801
Comparison of the effects of latanoprost and bimatoprost on central corneal thickness. Journal of glaucoma 20080801
Prostaglandin induces the expression of matrix metalloproteinase-1 in ciliary melanocytes. Chinese medical journal 20080705
Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines. Ophthalmology 20080701
[Intraocular pressure after instillation of amino acid arginine and combination of two antiglaucomatics (Trusopt + Xalatane mixture) in rabbits]. Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti 20080701
[Comparison of intraocular pressure lowering efficacy of bimatoprost / timolol fixed combination and other glaucoma medications in the treatment of glaucoma]. Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti 20080701
Predicting intraocular pressure change before initiating therapy: timolol versus latanoprost. Acta ophthalmologica 20080601
Contact dermatitis caused by latanoprost-containing eye drops with good tolerance to bimatoprost eye drops. Contact dermatitis 20080601
Recurring iris pigment epithelial cyst induced by topical prostaglandin F2 alpha analogues. Archives of ophthalmology (Chicago, Ill. : 1960) 20080601
Efficacy of latanoprost when stored at room temperature. Hiroshima journal of medical sciences 20080601
Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments. Experimental eye research 20080501
Brimonidine purite 0.1% versus brinzolamide 1% as adjunctive therapy to latanoprost in patients with glaucoma or ocular hypertension. Current medical research and opinion 20080501
The mechanisms by which latanoprost free acid inhibits human carbonic anhydrase I and II. Biological & pharmaceutical bulletin 20080501
Mechanism of action of bimatoprost, latanoprost, and travoprost in healthy subjects. A crossover study. Ophthalmology 20080501
A study of histopathological features of latanoprost-treated irides with or without darkening compared with non-latanoprost-treated irides. Archives of ophthalmology (Chicago, Ill. : 1960) 20080501
Gastrointestinal adverse effects of prostaglandin analogues. Archives of ophthalmology (Chicago, Ill. : 1960) 20080501
Topical and oral ketorolac administration increases the intraocular pressure-lowering effect of latanoprost. Current eye research 20080501
A cost-effectiveness analysis of fixed-combination therapies in patients with open-angle glaucoma: a European perspective. Current medical research and opinion 20080401
Effects of switching from topical beta-blockers to latanoprost on intraocular pressure in patients with normal-tension glaucoma. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20080401
Latanoprost-induced stabilization of central visual function in patients with primary open-angle glaucoma. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20080401
Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears. Cornea 20080401
Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension. The Annals of pharmacotherapy 20080401
[Comparative study of the effects of two anti-glaucomatous drugs on the corneal thickness in rabbits with corneal autografts]. Archivos de la Sociedad Espanola de Oftalmologia 20080401
Induction by latanoprost of collagen gel contraction mediated by human tenon fibroblasts: role of intracellular signaling molecules. Investigative ophthalmology & visual science 20080401
In vitro effects of preservative-free tafluprost and preserved latanoprost, travoprost, and bimatoprost in a conjunctival epithelial cell line. Current eye research 20080401
Meta-analysis of 13 randomized controlled trials comparing bimatoprost with latanoprost in patients with elevated intraocular pressure. Clinical therapeutics 20080401
First-line therapy with latanoprost 0.005% results in improved ocular circulation in newly diagnosed primary open-angle glaucoma patients: a prospective, 6-month, open-label study. Eye (London, England) 20080301
Bilateral iris cyst secondary to topical latanoprost. Acta ophthalmologica 20080301
Circadian changes of intraocular pressure and ocular perfusion pressure after timolol or latanoprost in Caucasians with normal-tension glaucoma. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20080301
Quality of diurnal intraocular pressure control in primary open-angle patients treated with latanoprost compared with surgically treated glaucoma patients: a prospective trial. The British journal of ophthalmology 20080301
Efficacy of the latanoprost versus timolol/dorzolamide combination therapy in patients with primary open angle glaucoma. Saudi medical journal 20080301
The efficacy of TonoLab in detecting physiological and pharmacological changes of mouse intraocular pressure--comparison with TonoPen and microneedle manometery. Current eye research 20080301
Comparison of twice-daily and three-times-daily dosing of dorzolamide in ocular hypertension and primary open-angle glaucoma patients treated with latanoprost. Advances in therapy 20080301
Intraocular pressure lowering effect of once daily versus once weekly latanoprost instillation in the same normal individuals. The Kobe journal of medical sciences 20080208
The effects of prostaglandin analogues on the blood aqueous barrier and corneal thickness of phakic patients with primary open-angle glaucoma and ocular hypertension. Eye (London, England) 20080201
Latanoprost does not affect immune privilege of corneal allografts. Experimental eye research 20080201
Inter-visit intraocular pressure range: an alternative parameter for assessing intraocular pressure control in clinical trials. American journal of ophthalmology 20080201
Presumed late diffuse lamellar keratitis progressing to interface fluid syndrome. Journal of cataract and refractive surgery 20080201
Iris morphology. Ophthalmology 20080201
Dorzolamide/timolol fixed combination versus latanoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension. Current eye research 20080201
Increase and decrease of measurements of iris density of glaucoma patients treated with latanoprost over 36 months. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20080201
Prostaglandins increase trabecular meshwork outflow facility in cultured human anterior segments. American journal of ophthalmology 20080101
Results of a study comparing the stability, efficacy, and adverse effect profile of innovator formulation, latanoprost (Xalatan) ophthalmic solution 0.005%, with that of a new formulation of a latanoprost ophthalmic solution containing cyclodextrins. Journal of clinical pharmacology 20080101
The efficacy and harm of prostaglandin analogues for IOP reduction in glaucoma patients compared to dorzolamide and brimonidine: a systematic review. The British journal of ophthalmology 20080101
Comparison of the 24-hour intraocular pressure-lowering effects of latanoprost and dorzolamide/timolol fixed combination after 2 and 6 months of treatment. Ophthalmology 20080101
Drug modification of angiogenesis in a rat cornea model. Investigative ophthalmology & visual science 20080101
Treatment carryover impacts on effectiveness of intraocular pressure lowering agents, estimated by a discrete event simulation model. European journal of ophthalmology 20080101
Comparison of intraocular pressure lowering effect of once daily morning vs evening dosing of latanoprost/timolol maleate combination. European journal of ophthalmology 20080101
Assessment of the cost effectiveness of travoprost versus latanoprost as single agents for treatment of glaucoma in France. Clinical drug investigation 20080101
The effect of latanoprost, bimatoprost, and travoprost on circadian variation of intraocular pressure in patients with open-angle glaucoma. Journal of glaucoma 20080101
Physician attitudes regarding prostaglandin treatment for glaucoma in the United States and Europe. European journal of ophthalmology 20080101
Macular edema associated with latanoprost use in a patient with idiopathic juxtafoveal retinal telangiectasis. Japanese journal of ophthalmology 20080101
Discrepancy of the intraocular pressure response between fellow eyes in one-eye trials versus bilateral treatment: verification with normal subjects. Journal of glaucoma 20080101
Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost. Journal of glaucoma 20080101
The effect of a single dose of topical 0.005% latanoprost and 2% dorzolamide/0.5% timolol combination on the blood-aqueous barrier in dogs: a pilot study. Veterinary ophthalmology 20080101
A 5-year, randomized, open-label safety study of latanoprost and usual care in patients with open-angle glaucoma or ocular hypertension. European journal of ophthalmology 20080101
Comparative study of the stability of bimatoprost 0.03% and latanoprost 0.005%: a patient-use study. BMC ophthalmology 20080101
Comparison of daytime efficacy and safety of dorzolamide/timolol maleate fixed combination versus latanoprost. European journal of ophthalmology 20080101
Performing meta-analysis with incomplete statistical information in clinical trials. BMC medical research methodology 20080101
A case of keratoconus progression associated with the use of topical latanoprost. Japanese journal of ophthalmology 20080101
Serous detachment of macula in cystoid macular edema associated with latanoprost. European journal of ophthalmology 20080101
The additive effects on intraocular pressure of combining nipradilol 0.25% and latanoprost 0.005% ophthalmic solutions: a prospective, randomized, multicenter study. Japanese journal of ophthalmology 20080101
Efficacy of TonoLab in detecting physiological and pharmacological changes in rat intraocular pressure: comparison of TonoPen and microneedle manometry. Japanese journal of ophthalmology 20080101
Intraocular pressure control with latanoprost/timolol and travoprost/timolol fixed combinations : a retrospective, multicentre, cross-sectional study. Clinical drug investigation 20080101
[Influence of topical latanoprost on foveal thickness in eyes that underwent uneventful cataract surgery]. Arquivos brasileiros de oftalmologia 20080101
[Considerations about administration angle of prostaglandin analogs]. Arquivos brasileiros de oftalmologia 20080101
[Fixed combinations of glaucoma medications]. Oftalmologia (Bucharest, Romania : 1990) 20080101
[Ocular surface disfunction in glaucoma]. Oftalmologia (Bucharest, Romania : 1990) 20080101
Effect on diurnal intraocular pressure of the fixed combination of latanoprost 0.005% and timolol 0.5% administered in the evening in glaucoma. Annals of ophthalmology (Skokie, Ill.) 20080101
[Open-angle glaucoma associated with Groenblad-Strandberg syndrome]. Oftalmologia (Bucharest, Romania : 1990) 20080101
Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure. Ophthalmology 20071201
Comparison of the effects of travoprost, latanoprost and bimatoprost on ocular circulation: a 6-month clinical trial. Acta ophthalmologica Scandinavica 20071201
Cystoid macular edema in a pseudophakic patient after switching from latanoprost to BAK-free travoprost. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20071201
Comparison of the effects of latanoprost and bimatoprost on intraocular pressure in chronic angle-closure glaucoma. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20071201
The clinical impact and incidence of periocular pigmentation associated with either latanoprost or bimatoprost therapy. Current eye research 20071201
Comparative efficacy of pilocarpine, timolol and latanoprost in experimental models of glaucoma. Methods and findings in experimental and clinical pharmacology 20071201
[Changes of the thickness of the ciliary body after the latanoprost 0.005 % application]. Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti 20071101
Adoption of new antiglaucoma drugs in Finland: impact of changes in copayment. Clinical therapeutics 20071101
A gap analysis approach to assess patient persistence with glaucoma medication. American journal of ophthalmology 20071001
Bilateral severe fibrinous anterior uveitis--an unusual complication of pamidronate therapy exacerbated by topical latanoprost. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20071001
Severe darkening of a facial skin graft from latanoprost. Archives of ophthalmology (Chicago, Ill. : 1960) 20071001
In vivo corneal epithelial permeability following treatment with prostaglandin analogs [correction of analoges] with or without benzalkonium chloride. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20071001
Effect of topical prostaglandin analog use on outcome following selective laser trabeculoplasty. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20071001
Evaluation of practice patterns for the care of open-angle glaucoma compared with claims data: the Glaucoma Adherence and Persistency Study. Ophthalmology 20070901
In vitro studies of antiglaucomatous prostaglandin analogues: travoprost with and without benzalkonium chloride and preserved latanoprost. Investigative ophthalmology & visual science 20070901
Effect of 15-keto latanoprost on intraocular pressure and aqueous humor dynamics in monkey eyes. Investigative ophthalmology & visual science 20070901
A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%. Clinical therapeutics 20070901
Monte Carlo simulation of latanoprost induced iris darkening. Computer methods and programs in biomedicine 20070801
Evidence for the involvement of cannabinoid CB1 receptors in the bimatoprost-induced contractions on the human isolated ciliary muscle. Investigative ophthalmology & visual science 20070801
A comparative, placebo-controlled study of prostanoid fluoroprostaglandin-receptor agonists tafluprost and latanoprost in healthy males. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20070801
Use of a Bayesian network to predict the nighttime intraocular pressure peak from daytime measurements. Clinical therapeutics 20070801
Hypotensive effect of profilin on rabbit intraocular pressure. European journal of pharmacology 20070712
Effect of age on the development of a latanoprost-induced increase in iris pigmentation. Ophthalmology 20070701
[Five years retrospective study of latanoprost glaucoma treatment]. Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti 20070701
Diurnal IOP control with bimatoprost versus latanoprost in exfoliative glaucoma: a crossover, observer-masked, three-centre study. The British journal of ophthalmology 20070601
Association between genetic polymorphisms of the prostaglandin F2alpha receptor gene and response to latanoprost. Ophthalmology 20070601
Clinical experience in the treatment of normal tension glaucoma with latanoprost in Germany. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20070601
[Glaucoma--the underestimated risk]. Kinderkrankenschwester : Organ der Sektion Kinderkrankenpflege 20070601
Medication adherence and health care costs with the introduction of latanoprost therapy for glaucoma in a Medicare managed care population. The American journal of geriatric pharmacotherapy 20070601
Morphometric effects of long-term exposure to latanoprost. Ophthalmology 20070501
Cellular and molecular effects of unoprostone as a BK channel activator. Biochimica et biophysica acta 20070501
Retrobulbar haemodynamic effects of the latanoprost/timolol and the dorzolamide/timolol fixed combinations in newly diagnosed glaucoma patients. International journal of clinical practice 20070501
A comparison of the safety and intraocular pressure lowering of bimatoprost/timolol fixed combination versus latanoprost/timolol fixed combination in patients with open-angle glaucoma. Current medical research and opinion 20070501
24-h IOP control with latanoprost, travoprost, and bimatoprost in subjects with exfoliation syndrome and ocular hypertension. Eye (London, England) 20070401
Efficacy and safety of latanoprost versus travoprost in exfoliative glaucoma patients. Ophthalmology 20070401
Influence of ocular hypotensive eyedrops on intraocular pressure fluctuation with postural change in eyes with normal-tension glaucoma. American journal of ophthalmology 20070401
Accounting for restart rates in evaluating persistence with ocular hypotensives. Ophthalmology 20070401
[Control of the rabbit's IOP after topic instillation of antiglaucomatic latanoprost and amino acid arginine with lysine mixture]. Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti 20070401
Hypotony and choroidal detachment as a complication of topical combined timolol and dorzolamide. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20070401
A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy. Current medical research and opinion 20070301
Relation between office intraocular pressure and 24-hour intraocular pressure in patients with primary open-angle glaucoma treated with a combination of topical antiglaucoma eye drops. Journal of glaucoma 20070301
Pseudophakic cystoid macular oedema: 30 months after latanoprost challenge. Eye (London, England) 20070201
Cessation of migraines in a woman with low-tension glaucoma following the use of latanoprost: a favourable side effect? Eye (London, England) 20070201
Latanoprost versus timolol gel-forming solution once daily in primary open-angle glaucoma or ocular hypertension. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20070201
Measurement of inflammatory cytokines by multicytokine assay in tears of patients with glaucoma topically treated with chronic drugs. The British journal of ophthalmology 20070101
Meta-analysis of randomised controlled trials comparing latanoprost with brimonidine in the treatment of open-angle glaucoma, ocular hypertension or normal-tension glaucoma. The British journal of ophthalmology 20070101
Intraocular pressure-lowering effect of adding dorzolamide or latanoprost to timolol: a meta-analysis of randomized clinical trials. Ophthalmology 20070101
Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost. Ophthalmic research 20070101
Choroidal detachment associated with latanoprost use in the fellow eye. The Annals of pharmacotherapy 20070101
Comparison of the stability, efficacy, and adverse effect profile of the innovator 0.005% latanoprost ophthalmic solution and a novel cyclodextrin-containing formulation. Journal of clinical pharmacology 20070101
Evaluation of the Xal-Ease latanoprost delivery system. Optometry (St. Louis, Mo.) 20070101
A randomized, crossover, open label pilot study to evaluate the efficacy and safety of Xalatan in comparison with generic Latanoprost (Latoprost) in subjects with primary open angle glaucoma or ocular hypertension. Indian journal of ophthalmology 20070101
[Changes of the physiological intraocular pressure (IOP) values after the application of latanoprost and amino acid glycine mixture in rabbits]. Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti 20070101
Midterm response with latanoprost therapy in german ocular hypertension patients. Current eye research 20070101
A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension. European journal of ophthalmology 20070101
Latanoprost-related transient incontinence. Clinical & experimental ophthalmology 20070101
Ocular hypotensive efficacy of brimonidine 0.15% as adjunctive therapy with latanoprost 0.005% in patients with open-angle glaucoma or ocular hypertension. Advances in therapy 20070101
Tolerability, quality of life, and persistency of use in patients with glaucoma who are switched to the fixed combination of latanoprost and timolol. Advances in therapy 20070101
Effect of concomitant use of latanoprost and brinzolamide on 24-hour variation of IOP in normal-tension glaucoma. Journal of glaucoma 20070101
Corneal edema after aqueous drainage device implantation. Journal of glaucoma 20070101
Effect of latanoprost acid and pilocarpine on cultured rabbit ciliary muscle cells. Ophthalmic research 20070101
Effects of latanoprost, timolol and GLC756, a novel dopamine D(2) agonist and D(1) antagonist on LTC(4) release after rat mast cell activation. Clinical & experimental ophthalmology 20070101
Pharmacoeconomic analysis of prostaglandin and prostamide therapy for patients with glaucoma or ocular hypertension. BMC ophthalmology 20070101
Refill rates and budget impact of glaucoma lipid therapy: a retrospective database analysis. Clinical drug investigation 20070101
The effect of ocular hypotensive agents on macula. Annals of ophthalmology (Skokie, Ill.) 20070101
Efficacy and safety of a systematic switch from latanoprost to travoprost in patients with glaucoma. Journal of glaucoma 20070101
Conjunctival changes induced by prostaglandin analogues and timolol maleate: a histomorphometric study. Arquivos brasileiros de oftalmologia 20070101
[Prostaglandin analogues and central corneal thickness]. Oftalmologia (Bucharest, Romania : 1990) 20070101
Effect of GLC756, a novel mixed dopamine D1 receptor antagonist and dopamine D2 receptor agonist, on TNF-alpha release in vitro from activated rat mast cells. Experimental eye research 20061201
Effects of latanoprost on rodent intraocular pressure. Experimental eye research 20061201
Comparison of the effects of latanoprost and travoprost on intraocular pressure in chronic angle-closure glaucoma. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20061201
Efficiency of instillation methods for prostaglandin medications. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20061201
Latanoprost rescues retinal neuro-glial cells from apoptosis by inhibiting caspase-3, which is mediated by p44/p42 mitogen-activated protein kinase. Experimental eye research 20061101
Clinical course of bimatoprost-induced periocular skin changes in Caucasians. Ophthalmology 20061101
Short-term effects of latanoprost on anterior chamber depth in patients with glaucoma or ocular hypertension. Investigative ophthalmology & visual science 20061101
Prostaglandin F2alpha, but not latanoprost, increases the Ca2+ sensitivity of the pig iris sphincter muscle. Investigative ophthalmology & visual science 20061101
Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials. Clinical & experimental ophthalmology 20061101
The state of being noninferior. Ophthalmology 20061101
24-Hour control with a latanoprost-timolol fixed combination vs timolol alone. Archives of ophthalmology (Chicago, Ill. : 1960) 20061101
Effect of latanoprost on the diurnal variations in the intraocular and ocular perfusion pressure in normal tension glaucoma. Journal of glaucoma 20061001
Allergic contact dermatitis caused by topical eye drops. American journal of ophthalmology 20061001
Comments on The cost-effectiveness of bimatoprost, latanoprost and timolol in treatment of primary open angle glaucoma in five European countries. Current medical research and opinion 20061001
A comparative analysis of the effects of the fixed combination of timolol and dorzolamide versus latanoprost plus timolol on ocular hemodynamics and visual function in patients with primary open-angle glaucoma. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20061001
Effect of previous argon laser trabeculoplasty on the ocular hypotensive action of latanoprost. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20060901
Successful management of orbital cellulitis and temporary visual loss after blepharoplasty. Plastic and reconstructive surgery 20060901
Effect of latanoprost on the expression of matrix metalloproteinases and their tissue inhibitors in human trabecular meshwork cells. Investigative ophthalmology & visual science 20060901
Circadian IOP-lowering efficacy of travoprost 0.004% ophthalmic solution compared to latanoprost 0.005%. Current medical research and opinion 20060901
Travoprost versus latanoprost combinations in glaucoma: economic evaluation based on visual field deficit progression. Current medical research and opinion 20060901
Effect of additive preoperative latanoprost treatment on the outcome of filtration surgery. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20060801
Neuroprotective effect of latanoprost on rat retinal ganglion cells. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20060801
Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial. Journal of glaucoma 20060801
Cost-effectiveness of monotherapy treatment of glaucoma and ocular hypertension with the lipid class of medications. American journal of ophthalmology 20060801
[Latanoprost induced COX2 during aqueous humor formation]. Medizinische Monatsschrift fur Pharmazeuten 20060801
[Side effects of antiglaucoma eye drops]. Nippon Ganka Gakkai zasshi 20060801
[Adverse reaction after use of latanoprost in Japanese glaucoma patients]. Nippon Ganka Gakkai zasshi 20060801
[Glaucoma: early diagnosis is central]. Praxis 20060705
Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma. Investigative ophthalmology & visual science 20060701
Effects of topical antiglaucoma application on conjunctival impression cytology specimens. American journal of ophthalmology 20060701
[The Slovak study of the travoprost treatment efficacy]. Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti 20060701
Melanin in the trabecular meshwork is associated with age, POAG but not Latanoprost treatment. A masked morphometric study. Experimental eye research 20060601
Comparison of invasive and non-invasive tonometry in the mouse. Experimental eye research 20060601
An evaluation of the rate of nonresponders to latanoprost therapy. Journal of glaucoma 20060601
Effects of antiglaucoma drugs on collagen gel contraction mediated by human corneal fibroblasts. Journal of glaucoma 20060601
[Efficacy of first- or second-line latanoprost on intraocular pressure and ocular symptoms in patients with open-angle glaucoma or ocular hypertension]. Journal francais d'ophtalmologie 20060601
The cost-effectiveness of bimatoprost, latanoprost and timolol in treatment of primary open angle glaucoma in five European countries. Current medical research and opinion 20060501
Adjunctive glaucoma therapy use associated with travoprost, bimatoprost, and latanoprost. Current medical research and opinion 20060501
[Effect of topical glaucoma medications on optic disc topography in normal tension glaucoma]. Nippon Ganka Gakkai zasshi 20060501
Syncope and falls due to timolol eye drops. BMJ (Clinical research ed.) 20060422
Selective laser trabeculoplasty as initial and adjunctive treatment for open-angle glaucoma. Journal of glaucoma 20060401
Efficacy of latanoprost or fixed-combination latanoprost-timolol in patients switched from a combination of timolol and a nonprostaglandin medication. Ophthalmology 20060301
Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost in patients with primary open angle glaucoma or ocular hypertension. The British journal of ophthalmology 20060301
Analysis of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human ciliary body after latanoprost. Investigative ophthalmology & visual science 20060301
A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension. Clinical therapeutics 20060301
Latanoprost therapy reduces the levels of TGF beta 1 and gelatinases in the aqueous humour of patients with exfoliative glaucoma. Experimental eye research 20060201
Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension. Ophthalmology 20060201
Nimesulide oral administration increases the intraocular pressure-lowering effect of latanoprost in patients with primary open-angle glaucoma. American journal of ophthalmology 20060201
The effect of latanoprost, bimatoprost, and travoprost on intraocular pressure after cataract surgery. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20060201
Hypertrichosis of the eyelashes from prostaglandin analog use: a blessing or a bother to the patient? Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20060201
A 12-week, randomized, double-masked, multicenter study of the fixed combination of latanoprost and timolol in the evening versus the individual components. Ophthalmology 20060101
Concentration of latanoprost ophthalmic solution after 4 to 6 weeks' use in an eye clinic setting. Investigative ophthalmology & visual science 20060101
Vasoactive responses of U46619, PGF2alpha, latanoprost, and travoprost in isolated porcine ciliary arteries. Investigative ophthalmology & visual science 20060101
Cost-effectiveness of monotherapy treatment of glaucoma and ocular hypertension with the lipid class of medications. American journal of ophthalmology 20060101
The state of being noninferior. Ophthalmology 20060101
A comparison of the effects of 0.005% latanoprost and fixed combination dorzolamide/timolol on retrobulbar haemodynamics in previously untreated glaucoma patients. Current medical research and opinion 20060101
Correlation between individual differences in intraocular pressure reduction and outflow facility due to latanoprost in normal-tension glaucoma patients. Japanese journal of ophthalmology 20060101
Comparison of the additive effects of nipradilol and carteolol to latanoprost in open-angle glaucoma. Japanese journal of ophthalmology 20060101
Correlation between the additive effect of bunazosin and the response to latanoprost on intraocular pressure in patients with glaucoma treated with bunazosin as adjunctive therapy to latanoprost. Japanese journal of ophthalmology 20060101
Estimated comparative costs of achieving a 20% reduction in intraocular pressure with bimatoprost or latanoprost in patients with glaucoma or ocular hypertension. Drugs & aging 20060101
Effects of latanoprost and GLC756, a novel dopamine D2 agonist and D1 antagonist, on cultured normal human dermal fibroblasts. European journal of ophthalmology 20060101
A comparison of travoprost, latanoprost, and the fixed combination of dorzolamide and timolol in patients with pseudoexfoliation glaucoma. European journal of ophthalmology 20060101
Effects of travoprost 0.004% compared with latanoprost 0.005% on the intraocular pressure of normal dogs. Veterinary ophthalmology 20060101
Cost considerations in the medical management of glaucoma in the US: estimated yearly costs and cost effectiveness of bimatoprost compared with other medications. PharmacoEconomics 20060101
Incidence of a latanoprost-induced increase in iris pigmentation in Japanese eyes. Japanese journal of ophthalmology 20060101
Latanoprost nonresponders with open-angle glaucoma in the Japanese population. Japanese journal of ophthalmology 20060101
Prospective comparative switch study from timolol 0.5% and latanoprost 0.005% to bimatoprost 0.03%. Advances in therapy 20060101
Side effects of glaucoma medications. Bulletin de la Societe belge d'ophtalmologie 20060101
The fading of reported effectiveness. A meta-analysis of randomised controlled trials. BMC medical research methodology 20060101
The comparison of eyelash lengthening effect of latanoprost therapy in adults and children. European journal of ophthalmology 20060101
Cost considerations in the medical management of glaucoma in the US: estimated yearly costs and cost effectiveness of bimatoprost compared with other medications. PharmacoEconomics 20060101
[Use of antiglaucoma therapy to reduce acute intraocular pressure rise following neodymium: YAG laser iridotomy in angle-closure glaucoma patients]. Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti 20060101
Additional reduction in intraocular pressure achieved with latanoprost in normal-tension glaucoma patients previously treated with unoprostone. Japanese journal of ophthalmology 20060101
A 3-month clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with normal-tension glaucoma. Advances in therapy 20060101
Allergic contact dermatitis caused by latanoprost ophthalmic solution. European journal of ophthalmology 20060101
Effects of latanoprost and betaxolol on cardiovascular and respiratory status of newly diagnosed glaucoma patients. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 20060101
Comparison of the relative toxicity of travoprost 0.004% without benzalkonium chloride and latanoprost 0.005% in an immortalized human cornea epithelial cell culture system. Advances in therapy 20060101
Assessment of corneal epithelial integrity after acute exposure to ocular hypotensive agents preserved with and without benzalkonium chloride. Advances in therapy 20060101
Comparison of diurnal intraocular pressure control by latanoprost versus travoprost : results of an observational survey. Clinical drug investigation 20060101
[Matrix-metalloproteinases and glaucoma]. Oftalmologia (Bucharest, Romania : 1990) 20060101
A comparison of latanoprost monotherapy with a combination therapy of timolol/dorzolamide in patients with primary open-angle glaucoma. Annals of ophthalmology (Skokie, Ill.) 20060101
Feasibility and efficacy of a mass switch from latanoprost to bimatoprost in glaucoma patients in a prepaid Health Maintenance Organization. Ophthalmology 20051201
In vitro comparison of cytoprotective and antioxidative effects of latanoprost, travoprost, and bimatoprost on conjunctiva-derived epithelial cells. Investigative ophthalmology & visual science 20051201
Lack of efficacy of topical latanoprost in the treatment of eyebrow alopecia areata. Journal of the American Academy of Dermatology 20051201
Comparison of latanoprost monotherapy and combined therapy of 0.5% timolol and 1% dorzolamide in chronic primary angle-closure glaucoma (CACG) in Japanese patients. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20051201
Profound sweating episodes and latanoprost. Clinical & experimental ophthalmology 20051201
The effect of latanoprost on intraocular pressure during 12 months of treatment for normal-tension glaucoma. Korean journal of ophthalmology : KJO 20051201
Stability of latanoprost in an ophthalmic lipid emulsion using polyvinyl alcohol. International journal of pharmaceutics 20051123
The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients. Experimental eye research 20051101
Latanoprost induces matrix metalloproteinase-1 expression in human nonpigmented ciliary epithelial cells through a cyclooxygenase-2-dependent mechanism. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20051101
A randomised, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open angle glaucoma. The British journal of ophthalmology 20051101
Toxic epidermal necrolysis secondary to timolol, dorzolamide, and latanoprost eyedrops. Journal of the American Academy of Dermatology 20051101
The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice. Investigative ophthalmology & visual science 20051101
Analytic review of bimatoprost, latanoprost and travoprost in primary open angle glaucoma. Current medical research and opinion 20051101
Characterization of a rabbit kidney prostaglandin F(2{alpha}) receptor exhibiting G(i)-restricted signaling that inhibits water absorption in the collecting duct. The Journal of biological chemistry 20051014
[Increasing ocular opacity in trisomy 13]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 20051001
The efficacy and ocular discomfort of substituting brinzolamide for dorzolamide in combination therapy with latanoprost, timolol, and dorzolamide. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20051001
Effect of latanoprost on cultured porcine corneal stromal cells. Current eye research 20051001
The cost-effectiveness of bimatoprost 0.03% in the treatment of glaucoma in adult patients--a European perspective. International journal of clinical practice 20050901
Effects of intratympanic injection of latanoprost in Meniere's disease: a randomized, placebo-controlled, double-blind, pilot study. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20050901
Clinical predictors of latanoprost treatment effect. Journal of glaucoma 20050801
Prostaglandins E1 and E2, but not F2alpha or latanoprost, inhibit monkey ciliary muscle contraction. Current eye research 20050801
Choroidal detachment after topical prostaglandin analogs: case report. Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20050801
[Variant angina associated with latanoprost]. Medicina clinica 20050709
Incidence and severity of iris pigmentation on latanoprost-treated glaucoma eyes. Eye (London, England) 20050701
Ocular and systemic side effects of latanoprost. Eye (London, England) 20050701
An uncommon presentation of acute angle closure glaucoma. The Journal of emergency medicine 20050701
In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells. Investigative ophthalmology & visual science 20050701
Twenty-four-hour control with latanoprost-timolol-fixed combination therapy vs latanoprost therapy. Archives of ophthalmology (Chicago, Ill. : 1960) 20050701
[Effects of latanoprost eye drops on the proliferation of human Tenon's fibroblasts in tissue culture]. [Zhonghua yan ke za zhi] Chinese journal of ophthalmology 20050701
Cost considerations of the new fixed combinations for glaucoma medical therapy. Journal of clinical pharmacy and therapeutics 20050601
How to control measurement variation in estimating the mean intraocular pressure reducing effect at a specific point in time. Contemporary clinical trials 20050601
Prostaglandin analogues and mouse intraocular pressure: effects of tafluprost, latanoprost, travoprost, and unoprostone, considering 24-hour variation. Investigative ophthalmology & visual science 20050601
Efficacy of the dorzolamide/timolol fixed combination versus latanoprost in the treatment of ocular hypertension or glaucoma: combined analysis of pooled data from two large randomized observer and patient-masked studies. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20050601
Effectiveness of latanoprost (Xalatan) monotherapy in newly discovered and previously medicamentously treated primary open angle glaucoma patients. Collegium antropologicum 20050601
Effects of the combination of bimatoprost and latanoprost on intraocular pressure in primary open angle glaucoma: a randomised clinical trial. The British journal of ophthalmology 20050501
Acute effects of PGF2alpha on MMP-2 secretion from human ciliary muscle cells: a PKC- and ERK-dependent process. Investigative ophthalmology & visual science 20050501
Influence of prostaglandin F2alpha and its analogues on hair regrowth and follicular melanogenesis in a murine model. Experimental dermatology 20050501
Lash ptosis caused by latanoprost. American journal of ophthalmology 20050501
Does adjunctive glaucoma therapy affect adherence to the initial primary therapy? Ophthalmology 20050501
[Changes of physiological intraocular pressure (IOP) in rabbits after administration of the amino acid lysine and the antiglaucoma drug latanoprost (Xalatan)]. Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti 20050501
Latanoprost or brimonidine as treatment for elevated intraocular pressure: multicenter trial in the United States. Journal of glaucoma 20050401
Corneal sensitivity changes following the instillation of latanoprost, bimatoprost, and travoprost eyedrops. American journal of ophthalmology 20050401
24-hour intraocular pressures with brimonidine purite versus dorzolamide added to latanoprost in primary open-angle glaucoma subjects. Ophthalmology 20050401
The efficacy and safety of topical brinzolamide and dorzolamide when added to the combination therapy of latanoprost and a beta-blocker in patients with glaucoma. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20050401
Intraocular pressure lowering effect of brinzolamide 1.0% as adjunctive therapy to latanoprost 0.005% in patients with open angle glaucoma or ocular hypertension: an uncontrolled, open-label study. Current medical research and opinion 20050401
Intraocular pressure control and persistence on treatment in glaucoma and ocular hypertension. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20050401
Efficacy and safety of latanoprost for glaucoma treatment: a three-month multicentric study in India. Indian journal of ophthalmology 20050301
[Circadian variations in intraocular pressure and their clinical implications]. Journal francais d'ophtalmologie 20050301
Comparison of additional intraocular pressure-lowering effects of latanoprost vs brimonidine in primary open-angle glaucoma patients with intraocular pressure uncontrolled by timolol-dorzolamide combination. Eye (London, England) 20050201
Tales of two drugs. Journal of glaucoma 20050201
Acute effects of glaucoma medications on rat intraocular pressure. Experimental eye research 20050201
Latanoprost 0.005% versus bimatoprost 0.03% in primary open-angle glaucoma patients. Ophthalmology 20050201
Degree of angle closure and the intraocular pressure-lowering effect of latanoprost in subjects with chronic angle-closure glaucoma. Ophthalmology 20050201
Blood-aqueous barrier changes after the use of prostaglandin analogues in patients with pseudophakia and aphakia: a 6-month randomized trial. Archives of ophthalmology (Chicago, Ill. : 1960) 20050201
Efficacy of latanoprost in patients with chronic angle-closure glaucoma and no visible ciliary-body face: a preliminary study. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20050201
Species differences in the effects of prostanoids on MAP kinase phosphorylation, myosin light chain phosphorylation and contraction in bovine and cat iris sphincter smooth muscle. Prostaglandins, leukotrienes, and essential fatty acids 20050101
Configuration of the drainage angle, intraocular pressure, and optic disc cupping in subjects with chronic angle-closure glaucoma. Ophthalmology 20050101
Potent reduction of intraocular pressure by nipradilol plus latanoprost in ocular hypertensive rabbits. Biological & pharmaceutical bulletin 20050101
Evaluation of the additive effect of bunazosin on latanoprost in primary open-angle glaucoma. Japanese journal of ophthalmology 20050101
[The more favourable cost/effectiveness ratio of latanoprost vs bimatoprost and travoprost when using normally for treatment of glaucoma]. Archivos de la Sociedad Espanola de Oftalmologia 20050101
Cystoid macular edema associated with latanoprost after uncomplicated cataract surgery. European journal of ophthalmology 20050101
Effects of glaucoma drugs on ocular hemodynamics in normal tension glaucoma: a randomized trial comparing bimatoprost and latanoprost with dorzolamide [ISRCTN18873428]. BMC ophthalmology 20050101
[Comparative analysis of life quality in patients receiving beta-blockers and xalathane (latanoprost)]. Vestnik oftalmologii 20050101
Comparative analysis of the efficacy and safety of latanoprost, travoprost and the fixed combination timolol-dorzolamide; a prospective, randomized, masked, cross-over design study. Oftalmologia (Bucharest, Romania : 1990) 20050101
[Primary infantile glaucoma with late diagnosis--case report]. Oftalmologia (Bucharest, Romania : 1990) 20050101
[Axial length of the ocular globe and hypotensive effect in glaucoma therapy with prostaglandin analogs]. Oftalmologia (Bucharest, Romania : 1990) 20050101
Daytime diurnal curve comparison between the fixed combinations of latanoprost 0.005%/timolol maleate 0.5% and dorzolamide 2%/timolol maleate 0.5%. Eye (London, England) 20041201
Prostaglandin FP agonists alter metalloproteinase gene expression in sclera. Investigative ophthalmology & visual science 20041201
Poliosis associated with treatment of fungal endophthalmitis. Orbit (Amsterdam, Netherlands) 20041201
A comparison of the effects of dorzolamide/timolol fixed combination versus latanoprost on intraocular pressure and pulsatile ocular blood flow in primary open-angle glaucoma patients. Acta ophthalmologica Scandinavica 20041201
Stopping prostaglandin analogues in uneventful cataract surgery. Journal of cataract and refractive surgery 20041201
Two-year follow-up of latanoprost 0.005% monotherapy after changing from previous glaucoma therapies. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20041201
Persistency and treatment failure in newly diagnosed open angle glaucoma patients in the United Kingdom. The British journal of ophthalmology 20041101
A study of iridectomy histopathologic features of latanoprost- and non-latanoprost-treated patients. Archives of ophthalmology (Chicago, Ill. : 1960) 20041101
[Comparison of once-daily nonpreserved timolol and timolol maleate gel-forming solution associated with latanoprost]. Journal francais d'ophtalmologie 20041101
A three-year prospective, randomized and open comparison between latanoprost and timolol in Japanese normal-tension glaucoma patients. Eye (London, England) 20041001
Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy. Eye (London, England) 20041001
Reversal of disc cupping after intraocular pressure reduction in topographic image series. Journal of glaucoma 20041001
Short term efficacy and safety in glaucoma patients changed to the latanoprost 0.005%/timolol maleate 0.5% fixed combination from monotherapies and adjunctive therapies. The British journal of ophthalmology 20041001
Effect of latanoprost on intraocular pressure in mice lacking the prostaglandin FP receptor. Investigative ophthalmology & visual science 20041001
Analysis of irises with a latanoprost-induced change in iris color. American journal of ophthalmology 20041001
Switching from latanoprost to fixed-combination latanoprost-timolol: a 21-day, randomized, double-masked, active-control study in patients with glaucoma and ocular hypertension. Clinical therapeutics 20041001
[Measurement of corneal thickness in cases where tonometry is contraindicated]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 20041001
Intraocular pressure and safety in glaucoma patients switching to latanoprost/timolol maleate fixed combination from mono- and adjunctive therapies. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20041001
A persistency and economic analysis of latanoprost, bimatoprost, or beta-blockers in patients with open-angle glaucoma or ocular hypertension. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20041001
Intraocular pressure fluctuations in response to the water-drinking provocative test in patients using latanoprost versus unoprostone. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20041001
Diurnal intraocular pressure reduction with latanoprost 0.005% compared to timolol maleate 0.5% as monotherapy in subjects with exfoliation glaucoma. Eye (London, England) 20040901
A 6-month randomized clinical trial of bimatoprost 0.03% versus the association of timolol 0.5% and latanoprost 0.005% in glaucomatous patients. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20040901
[Circadian rhythm variations of intraocular pressure and therapeutic decisions: interpretation of clinical trial results based on a statistical model]. Journal francais d'ophtalmologie 20040901
Comparison of the nocturnal effects of once-daily timolol and latanoprost on intraocular pressure. American journal of ophthalmology 20040901
Additivity of bimatoprost or travoprost to latanoprost in glaucomatous monkey eyes. Archives of ophthalmology (Chicago, Ill. : 1960) 20040901
Concomitant administration of travoprost and brinzolamide versus fixed latanoprost/timolol combined therapy: three-month comparison of efficacy and safety. Current medical research and opinion 20040901
Ocular hypotensive efficacy of travoprost in patients unsuccessfully treated with latanoprost. Current medical research and opinion 20040901
[Impact of prostaglandin-F(2alpha)-analogues and carbonic anhydrase inhibitors on central corneal thickness -- a cross-sectional study on 403 eyes]. Klinische Monatsblatter fur Augenheilkunde 20040901
[Reaction of the physiological IOP in rabbits after application of the latanoprost (Xalatan) and amino acid L-arginine HCl mixture]. Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti 20040901
Effects of bunazosin hydrochloride on ciliary muscle constriction and matrix metalloproteinase activities. Journal of glaucoma 20040801
The influence of Latanoprost 0.005% on aqueous humor flow and outflow facility in glaucoma patients: a double-masked placebo-controlled clinical study. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20040801
Short-term effect of latanoprost on ocular circulation in ocular hypertension. Clinical & experimental ophthalmology 20040801
Latanoprost exposure in pregnancy. American journal of ophthalmology 20040801
The efficacy and safety of once-daily versus once-weekly latanoprost treatment for increased intraocular pressure. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20040801
[Short and long-term hypotensive effect of timolol-gel and latanoprost instillation in normal-tension glaucoma]. Nippon Ganka Gakkai zasshi 20040801
A comparison of the fixed combination of latanoprost and timolol with the unfixed combination of brimonidine and timolol in patients with elevated intraocular pressure. A six month, evaluator masked, multicentre study in Europe. The British journal of ophthalmology 20040701
Effect of latanoprost on outflow facility in the mouse. Investigative ophthalmology & visual science 20040701
A 5-year, multicenter, open-label, safety study of adjunctive latanoprost therapy for glaucoma. Archives of ophthalmology (Chicago, Ill. : 1960) 20040701
[New informations on medical treatment for normal-tension glaucoma]. Nippon Ganka Gakkai zasshi 20040701
[Comparison of the effects of latanoprost and timolol gel-forming solution on diurnal variation of intraocular pressure in normal-tension glaucoma]. Nippon Ganka Gakkai zasshi 20040701
Inhibitory effects of anti-glaucoma drugs on corneal epithelial migration in a rabbit organ culture system. Journal of glaucoma 20040601
Trends in glaucoma surgery before and after the introduction of new topical glaucoma pharmacotherapies. Journal of glaucoma 20040601
Latanoprost eye drops increase concentration of glycosaminoglycans in posterior rabbit sclera. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20040601
[Cataract surgery and prostaglandin analogs? Yes, but under certain conditions]. Journal francais d'ophtalmologie 20040601
Latanoprost-induced pigmentation in human iridial melanocytes is fibroblast dependent. Experimental eye research 20040501
Long term effect of latanoprost on intraocular pressure in normal tension glaucoma. The British journal of ophthalmology 20040501
Relation between axial length of the eye and hypotensive effect of latanoprost in primary open angle glaucoma. The British journal of ophthalmology 20040501
Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study. Investigative ophthalmology & visual science 20040501
Topical prostaglandin F(2alpha) analog induced poliosis. American journal of ophthalmology 20040501
Cystoid macular edema in a low-risk patient after switching from latanoprost to bimatoprost. American journal of ophthalmology 20040501
Comparison of latanoprost with fixed-combination dorzolamide and timolol in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label, parallel-group, multicenter study in Latin America. Clinical therapeutics 20040501
Studies on ocular inflammation and development of a prostaglandin analogue for glaucoma treatment. Experimental eye research 20040401
Pharmacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug. Experimental eye research 20040401
Assessment of chamber angle pigmentation during longterm latanoprost treatment for open-angle glaucoma. Acta ophthalmologica Scandinavica 20040401
An evaluation of the fixed-combination of latanoprost and timolol for use in open-angle glaucoma and ocular hypertension. Expert opinion on pharmacotherapy 20040401
[Recent changes in glaucoma management]. Nippon Ganka Gakkai zasshi 20040401
[The effect of substituting latanoprost 0.005% for unoprostone 0.12%]. Nippon Ganka Gakkai zasshi 20040401
Choroidal detachment with topical latanoprost after glaucoma filtration surgery. The Annals of pharmacotherapy 20040301
Tonometric changes of latanoprost-induced intraocular pressure reduction after photorefractive keratectomy. Investigative ophthalmology & visual science 20040301
Conjunctival pigmentation as an adverse effect of latanoprost. Eye (London, England) 20040301
A randomized, investigator-masked comparison of diurnal responder rates with bimatoprost and latanoprost in the lowering of intraocular pressure. Survey of ophthalmology 20040301
24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial. Survey of ophthalmology 20040301
A cost-effectiveness comparison of bimatoprost versus latanoprost in patients with glaucoma or ocular hypertension. Survey of ophthalmology 20040301
Intraocular pressure-reducing effects and safety of latanoprost versus timolol in patients with chronic angle-closure glaucoma. Ophthalmology 20040301
Efficacy of bunazosin hydrochloride 0.01% as adjunctive therapy of latanoprost or timolol. Journal of glaucoma 20040201
Effects of prostaglandin F2alpha, latanoprost and carbachol on phosphoinositide turnover, MAP kinases, myosin light chain phosphorylation and contraction and functional existence and expression of FP receptors in bovine iris sphincter. Experimental eye research 20040201
A 12 week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertension. The British journal of ophthalmology 20040201
Crossover comparison of timolol and latanoprost in chronic primary angle-closure glaucoma. Archives of ophthalmology (Chicago, Ill. : 1960) 20040201
A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator, multicenter study. American journal of ophthalmology 20040201
Efficacy and tolerability of the dorzolamide 2%/timolol 0.5% combination (COSOPT) versus 0.005% (XALATAN) in the treatment of ocular hypertension or glaucoma: results from two randomized clinical trials. Acta ophthalmologica Scandinavica 20040201
Pharmacological characterization and identification of EP3 prostanoid receptor binding sites in hamster uterus homogenates. The Journal of pharmacy and pharmacology 20040201
Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure. Ophthalmology 20040201
Brimonidine and latanoprost as adjunctive therapy. Ophthalmology 20040201
Persistency with latanoprost or timolol in primary open-angle glaucoma suspects. American journal of ophthalmology 20040101
Comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. American journal of ophthalmology 20040101
Comparison of the diurnal ocular hypotensive efficacy of travoprost and latanoprost over a 44-hour period in patients with elevated intraocular pressure. Clinical therapeutics 20040101
A prospective study of iridial pigmentation and eyelash changes due to ophthalmic treatment with latanoprost. Japanese journal of ophthalmology 20040101
Latanoprost therapy in patients with glaucoma and ocular hypertension inadequately controlled with carteolol. Japanese journal of ophthalmology 20040101
Comparison of latanoprost and dorzolamide in the treatment of patients with open angle glaucoma. Journal of Ayub Medical College, Abbottabad : JAMC 20040101
Switch to latanoprost monotherapy from combined treatment with beta-antagonist and other antiglaucoma agents in patients with glaucoma or ocular hypertension. Japanese journal of ophthalmology 20040101
Effects of betaxolol and latanoprost on ocular blood flow and visual fields in patients with primary open-angle glaucoma. European journal of ophthalmology 20040101
[Timolol topical ophthalmic combination]. Oftalmologia (Bucharest, Romania : 1990) 20040101
Prostaglandin analogs and blood-aqueous barrier integrity: a flare cell meter study. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 20040101
[Neuroprotection and vasoprotection in glaucoma]. Oftalmologia (Bucharest, Romania : 1990) 20040101
Switching to latanoprost monotherapy for 24 weeks in glaucoma patients. European journal of ophthalmology 20040101
Intraocular pressure, safety and quality of life in glaucoma patients switching to latanoprost from adjunctive and monotherapy treatments. European journal of ophthalmology 20040101
[The effectiveness of latanoprost for the treatment of pediatric glaucoma]. Klinika oczna 20040101
[Theoretical and clinical aspects of the use of prostaglandins in glaucoma therapy]. Klinika oczna 20040101
A cost-effectiveness comparison of bimatoprost versus latanoprost in patients with glaucoma or ocular hypertension. Survey of ophthalmology 20040101
Effect of latanoprost 0.005% and brimonidine 0.2% on intraocular pressure after phacoemulsification and intraocular lens implantation surgery. Japanese journal of ophthalmology 20040101
Latanoprost and pigmentation. Japanese journal of ophthalmology 20040101
Efficacy of latanoprost and timolol maleate in black and white patients. Advances in therapy 20040101
Bimatoprost versus latanoprost in lowering intraocular pressure in glaucoma and ocular hypertension: results from parallel-group comparison trials. Advances in therapy 20040101
[Latanoprost topical ophthalmic combinations]. Oftalmologia (Bucharest, Romania : 1990) 20040101
In vitro effects of preserved and unpreserved antiglaucoma drugs on apoptotic marker expression by human trabecular cells. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20031201
Latanoprost-induced iris darkening: a morphometric study of human peripheral iridectomies. Experimental eye research 20031201
Latanoprost stimulates secretion of matrix metalloproteinases in tenon fibroblasts both in vitro and in vivo. Investigative ophthalmology & visual science 20031201
New fluoroprostaglandin F(2alpha) derivatives with prostanoid FP-receptor agonistic activity as potent ocular-hypotensive agents. Biological & pharmaceutical bulletin 20031201
Pooled-data analysis of three randomized, double-masked, six-month studies comparing intraocular pressure-reducing effects of latanoprost and timolol in patients with ocular hypertension. Journal of glaucoma 20031201
Rate of response to latanoprost or timolol in patients with ocular hypertension or glaucoma. Journal of glaucoma 20031201
Corneal punctate staining with latanoprost, bimatoprost, and travoprost in healthy subjects. Journal of glaucoma 20031201
Ocular factors relevant to anti-glaucomatous eyedrop-related keratoepitheliopathy. Journal of glaucoma 20031201
Thyroid eye disease and glaucoma. Journal of glaucoma 20031201
Intraocular pressure after replacement of current dual therapy with latanoprost monotherapy in patients with open angle glaucoma. The British journal of ophthalmology 20031201
Posner-Schlossman syndrome and nonarteritic anterior ischemic optic neuropathy. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 20031201
Efficacy and safety of brimonidine, dorzolamide and latanoprost as adjunctive therapy in primary open angle glaucoma. International journal of clinical practice 20031201
Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20031201
A study of replacement of timolol-pilocarpine with latanoprost in pseudoexfoliation glaucoma. Collegium antropologicum 20031201
Acute myopia and angle-closure glaucoma induced by topiramate. Neurology 20031111
Morphological changes in the anterior eye segment after long-term treatment with different receptor selective prostaglandin agonists and a prostamide. Investigative ophthalmology & visual science 20031001
Evaluation of retinal haemodynamics and retinal function after application of dorzolamide, timolol and latanoprost in newly diagnosed open-angle glaucoma patients. Acta ophthalmologica Scandinavica 20031001
The prostaglandin wars. American journal of ophthalmology 20031001
Iris cyst secondary to latanoprost mimicking iris melanoma. American journal of ophthalmology 20031001
Assessing the cost-effectiveness of switching from a beta-blocker to latanoprost in the treatment of ocular hypertension. Expert opinion on pharmacotherapy 20031001
Interventions for angle-closure glaucoma: an evidence-based update. Ophthalmology 20031001
In vitro effects of preserved or preservative-free antiglaucoma medications on human complement system. Current eye research 20031001
Intraocular pressure, safety, and quality of life in glaucoma patients switching to latanoprost from monotherapy treatments. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20031001
Prescription of topical antiglaucoma agents for patients with contraindications to beta-blockers. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20031001
Latanoprost in port wine stain related paediatric glaucoma. The British journal of ophthalmology 20030901
Latanoprost versus bimatoprost. Ophthalmology 20030901
ESCRS Binkhorst lecture 2002: Pseudophakic preservative maculopathy. Journal of cataract and refractive surgery 20030901
[Effect of latanoprost on diurnal variations of intraocular pressure in normal-tension glaucoma]. Nippon Ganka Gakkai zasshi 20030901
Comparison of iridial pigmentation between latanoprost and isopropyl unoprostone: a long term prospective comparative study. The British journal of ophthalmology 20030801
Six-month randomized clinical trial comparing intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma. American journal of ophthalmology 20030801
Effects of 0.005% latanoprost on ocular anterior structures and ciliary body thickness. Journal of glaucoma 20030801
Which endpoint: mean intraocular pressure or proportion of successful patients? Journal of glaucoma 20030801
Replacing maximum-tolerated medications with latanoprost versus adding latanoprost to maximum-tolerated medications: a two-center randomized prospective trial. Journal of glaucoma 20030801
Prostaglandin analogs for hair growth: great expectations. Dermatology online journal 20030801
[Relative contraindication of latanoprost in iris tumors with secondary glaucoma]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 20030801
Glaucoma. Eye series. 7. Australian family physician 20030801
Randomized clinical trial comparing intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma. American journal of ophthalmology 20030701
An iris coloboma preventing pigmentary glaucoma. Archives of ophthalmology (Chicago, Ill. : 1960) 20030701
Twenty-four-hour diurnal curve comparison of commercially available latanoprost 0.005% versus the timolol and dorzolamide fixed combination. Ophthalmology 20030701
Persistency and clinical outcomes associated with latanoprost and beta-blocker monotherapy: evidence from a European retrospective cohort study. European journal of ophthalmology 20030701
Clinical and economic impacts of latanoprost 0.005% in first-line treatment of open-angle glaucoma and ocular hypertension in France. European journal of ophthalmology 20030701
Patient persistency with pharmacotherapy in the management of glaucoma. European journal of ophthalmology 20030701
Peak pressures: crossover study of timolol and latanoprost. European journal of ophthalmology 20030701
Impression cytology of the conjunctival epithelium after antiglaucomatous treatment with latanoprost. European journal of ophthalmology 20030701
Efficacy and safety of timolol maleate/latanoprost fixed combination versus timolol maleate and brimonidine given twice daily. Acta ophthalmologica Scandinavica 20030601
A six-month randomized clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma. American journal of ophthalmology 20030601
Human lens epithelial cell damage and stimulation of their secretion of chemical mediators by benzalkonium chloride rather than latanoprost and timolol. Archives of ophthalmology (Chicago, Ill. : 1960) 20030601
Ocular hypotensive efficacy of bimatoprost when used as a replacement for latanoprost in the treatment of glaucoma and ocular hypertension. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20030601
Effects of commercial antiglaucoma drugs to glutamate-induced [Ca2+)]i increase in cultured neuroblastoma cells. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20030601
Effects of prostaglandin F2alpha and latanoprost on phosphoinositide turnover, myosin light chain phosphorylation and contraction in cat iris sphincter. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20030601
The effects of Xalatan on the recovery of ocular herpes simplex virus type 1 (HSV-1) in the induced reactivation and spontaneous shedding rabbit models. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20030601
Comparison between latanoprost and brimonidine efficacy and safety in Indian eyes. Indian journal of ophthalmology 20030601
Latanoprost and cystoid macular edema. Journal of cataract and refractive surgery 20030601
Latanoprost and cystoid macular edema. Journal of cataract and refractive surgery 20030601
Latanoprost and cystoid macular edema. Journal of cataract and refractive surgery 20030601
Sex hormone effects in non-pregnant rat and human myometrium. European journal of obstetrics, gynecology, and reproductive biology 20030501
Effects of prostaglandin analogues on human ciliary muscle and trabecular meshwork cells. Investigative ophthalmology & visual science 20030501
A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. American journal of ophthalmology 20030501
Increased periocular pigmentation with ocular hypotensive lipid use in African Americans. American journal of ophthalmology 20030501
Normal-tension glaucoma. Journal of glaucoma 20030401
The effect of latanoprost, brimonidine, and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with glaucoma or ocular hypertension. Archives of ophthalmology (Chicago, Ill. : 1960) 20030401
Update on prostaglandin analogs. Current opinion in ophthalmology 20030401
Systemic side effects of topical latanoprost. Eye (London, England) 20030401
Cutaneous latanoprost in the treatment of alopecia areata. Eye (London, England) 20030401
The effects of latanoprost and brimonidine on blood flow velocity of the retrobulbar vessels: a 3-month clinical trial. Acta ophthalmologica Scandinavica 20030401
Patient persistency with ocular prostaglandin therapy: a population-based, retrospective study. Clinical therapeutics 20030401
Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost. The British journal of ophthalmology 20030301
Iris pigment epithelial cyst induced by topical administration of latanoprost. The British journal of ophthalmology 20030301
Conjunctival hyperemia in healthy subjects after short-term dosing with latanoprost, bimatoprost, and travoprost. American journal of ophthalmology 20030301
Iris cyst secondary to latanoprost mimicking iris melanoma. American journal of ophthalmology 20030301
Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost. Ophthalmology 20030301
Vitrectomy for phacolytic glaucoma in a patient with ectopia lentis et pupillae. Eye (London, England) 20030301
Four years later: a clinical update on latanoprost. European journal of ophthalmology 20030301
Cystoid macular edema associated with latanoprost therapy in a pseudophakic vitrectomized patient after removal of silicone oil endotamponade. European journal of ophthalmology 20030301
Transcription of prostanoid receptor genes and cyclooxygenase enzyme genes in cultivated human iridial melanocytes from eyes of different colours. Pigment cell research 20030201
Human trabecular meshwork cell responses induced by bimatoprost, travoprost, unoprostone, and other FP prostaglandin receptor agonist analogues. Investigative ophthalmology & visual science 20030201
Noninvasive assessment of aqueous humor turnover in the mouse eye. Investigative ophthalmology & visual science 20030201
The effect of latanoprost on accommodation in young patients with ocular hypertension. Journal of glaucoma 20030201
New topical drugs for open-angle glaucoma. Drug and therapeutics bulletin 20030201
Conjunctival hyperemia and the use of topical prostaglandins in glaucoma and ocular hypertension. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20030201
A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma. American journal of ophthalmology 20030101
Brimonidine and latanoprost as adjunctive therapy. Ophthalmology 20030101
Fine structural evaluation of the iris after unilateral treatment with latanoprost in patients undergoing bilateral trabeculectomy (the Mainz II study). Archives of ophthalmology (Chicago, Ill. : 1960) 20030101
A standardized approach for iris color determination. International journal of toxicology 20030101
The efficacy and safety of the timolol/dorzolamide fixed combination vs latanoprost in exfoliation glaucoma. Eye (London, England) 20030101
Nurse prescribing in glaucoma. Eye (London, England) 20030101
Comparison of the intraocular pressure lowering effect of latanoprost and carteolol-pilocarpine combination in newly diagnosed glaucoma. Japanese journal of ophthalmology 20030101
Cystoid macular edema associated with latanoprost use in a pseudophakic eye with a history of surgical complications. Japanese journal of ophthalmology 20030101
[Increased myopia and metaporphosia in a 59-year old patient. Serous retinal detachment of the posterior pol after latanoprost administration]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 20030101
Comparative analysis of the effects of dorzolamide and latanoprost on ocular hemodynamics in normal tension glaucoma patients. European journal of ophthalmology 20030101
Corneal neovascularization possibly associated with latanoprost therapy. European journal of ophthalmology 20030101
Experience with COSOPT, the fixed combination of timolol and dorzolamide, gained in Swiss ophthalmologists' offices. Current medical research and opinion 20030101
Brimonidine Purite and bimatoprost compared with timolol and latanoprost in patients with glaucoma and ocular hypertension. Advances in therapy 20030101
Latanoprost : an update of its use in glaucoma and ocular hypertension. Drugs & aging 20030101
The free amino acids and the aqueous humor pH after antiglaucomatics in vitro. Bratislavske lekarske listy 20030101
Comparison of brimonidine/latanoprost and timolol/dorzolamide: two randomized, double-masked, parallel clinical trials. Advances in therapy 20030101
Effects of latanoprost on blood-retinal barrier permeability in rabbits. Ophthalmic research 20030101
Response to travoprost in black and nonblack patients with open-angle glaucoma or ocular hypertension. Advances in therapy 20030101
A short-term study of the additive effect of latanoprost 0.005% and brimonidine 0.2%. Japanese journal of ophthalmology 20030101
Additive effect of bunazosin on intraocular pressure when topically added to treatment with latanoprost in patients with glaucoma. Japanese journal of ophthalmology 20030101
Acute angle-closure glaucoma associated with latanoprost. Japanese journal of ophthalmology 20030101
Interventions for normal tension glaucoma. The Cochrane database of systematic reviews 20030101
Bullous keratopathy after argon laser iridotomy presumably associated with latanoprost. Japanese journal of ophthalmology 20030101
Latanoprost's effects on TIMP-1 and TIMP-2 expression in human ciliary muscle cells. Investigative ophthalmology & visual science 20021201
Changes in intraocular pressure and ocular perfusion pressure after latanoprost 0.005% or brimonidine tartrate 0.2% in normal-tension glaucoma patients. Ophthalmology 20021201
Randomized clinical trial of latanoprost and unoprostone in patients with elevated intraocular pressure. American journal of ophthalmology 20021201
An update on bimatoprost in glaucoma therapy. Expert opinion on pharmacotherapy 20021201
A comparative clinical study of latanoprost and isopropyl unoprostone in Japanese patients with primary open-angle glaucoma and ocular hypertension. Journal of glaucoma 20021201
A comparison of the effects on intraocular pressure of latanoprost 0.005% and the fixed combination of dorzolamide 2% and timolol 0.5% in patients with open-angle glaucoma. Acta ophthalmologica Scandinavica 20021201
Evaluation of the intraocular pressure-reducing effect of latanoprost as monotherapy in open-angle glaucoma. Collegium antropologicum 20021201
[Drug therapy for residual angle-closure glaucoma after laser iridectomy]. [Zhonghua yan ke za zhi] Chinese journal of ophthalmology 20021201
Effect of a single drop of latanoprost on intraocular pressure and blood-aqueous barrier permeability in patients with uveitis. The Kobe journal of medical sciences 20021201
Effect of latanoprost 0.005% and brimonidine tartrate 0.2% on pulsatile ocular blood flow in normal tension glaucoma. The British journal of ophthalmology 20021101
Primary glaucoma in Burmese cats. Australian veterinary journal 20021101
A comparison of the fixed combination of latanoprost and timolol with its individual components. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20021101
Incidence of iris colour change in latanoprost treated eyes. The British journal of ophthalmology 20021001
Comparative effects of latanoprost (Xalatan) and unoprostone (Rescula) in patients with open-angle glaucoma and suspected glaucoma. American journal of ophthalmology 20021001
Latanoprost and clinically significant cystoid macular edema after uneventful phacoemulsification with intraocular lens implantation. Journal of cataract and refractive surgery 20021001
[Respiratory effects of chronic therapy with latanoprost in patients with chronic obstructive pulmonary disease (COPD)]. Archivos de la Sociedad Espanola de Oftalmologia 20021001
Production of prostaglandin e(2) by iridial melanocytes exposed to latanoprost acid, a prostaglandin F(2 alpha) analogue. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20021001
Quantitative analysis of eyelash lengthening following topical latanoprost therapy. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20021001
[Side-effects and risk profile of latanoprost 0.005% (Xalatan)]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 20020901
Effect of treatment by medicine or surgery on intraocular pressure and pulsatile ocular blood flow in normal-pressure glaucoma. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20020901
Reappraising first-line treatment in glaucoma management. Hospital medicine (London, England : 1998) 20020901
Cost analysis of glaucoma medications: a 3-year review. Journal of glaucoma 20020801
An economic analysis of switching to latanoprost from a beta-blocker or adding brimonidine or latanoprost to a beta-blocker in open-angle glaucoma or ocular hypertension. The American journal of managed care 20020801
Population-based persistency rates for topical glaucoma medications measured with pharmacy claims data. The American journal of managed care 20020801
Rates of discontinuation and change of glaucoma therapy in a managed care setting. The American journal of managed care 20020801
Discontinuation rates of topical glaucoma medications in a managed care population. The American journal of managed care 20020801
Ocular and systemic pharmacokinetics of latanoprost in humans. Survey of ophthalmology 20020801
The effect of latanoprost on intraocular pressure during 2 years of treatment. Survey of ophthalmology 20020801
The effect of latanoprost compared with timolol in African-American, Asian, Caucasian, and Mexican open-angle glaucoma or ocular hypertensive patients. Survey of ophthalmology 20020801
The effect of latanoprost on circadian intraocular pressure. Survey of ophthalmology 20020801
Current status of prostaglandin therapy: latanoprost and unoprostone. Survey of ophthalmology 20020801
Bimatoprost and travoprost: a review of recent studies of two new glaucoma drugs. Survey of ophthalmology 20020801
Efficacy of latanoprost in reducing intraocular pressure in patients with primary angle-closure glaucoma. Survey of ophthalmology 20020801
Latanoprost for the treatment of pediatric glaucoma. Survey of ophthalmology 20020801
The efficacy and safety of unfixed and fixed combinations of latanoprost and other antiglaucoma medications. Survey of ophthalmology 20020801
Latanoprost and cholinergic agonists in combination. Survey of ophthalmology 20020801
Latanoprost versus combined timolol and dorzolamide. Survey of ophthalmology 20020801
Combined therapy of pilocarpine or latanoprost with timolol versus latanoprost monotherapy. Survey of ophthalmology 20020801
Mechanism and clinical significance of prostaglandin-induced iris pigmentation. Survey of ophthalmology 20020801
Histology and fine structure of the iris and outflow system following latanoprost therapy. Survey of ophthalmology 20020801
Prostaglandin-induced hair growth. Survey of ophthalmology 20020801
Prostaglandins and cystoid macular edema. Survey of ophthalmology 20020801
Agonist activity of bimatoprost, travoprost, latanoprost, unoprostone isopropyl ester and other prostaglandin analogs at the cloned human ciliary body FP prostaglandin receptor. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20020801
Effect of hyaluronic acid on intraocular pressure in rats. Investigative ophthalmology & visual science 20020701
Predictive value of a 1-day, 1-eye trial on the 1-month ocular hypotensive response of latanoprost 0.005%. American journal of ophthalmology 20020701
Latanoprost and timolol combination therapy vs monotherapy: one-year randomized trial. Archives of ophthalmology (Chicago, Ill. : 1960) 20020701
A comparison of once-daily morning vs evening dosing of concomitant latanoprost/timolol. American journal of ophthalmology 20020601
Additive intraocular pressure lowering effect of various medications with latanoprost. American journal of ophthalmology 20020601
Paradoxical intraocular pressure elevation after combined therapy with latanoprost and bimatoprost. Archives of ophthalmology (Chicago, Ill. : 1960) 20020601
Use of latanoprost to reduce acute intraocular pressure rise following neodymium: Yag laser iridotomy. Acta ophthalmologica Scandinavica 20020601
A retrospective review of non-responders to latanoprost. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20020601
The efficacy of latanoprost is independent of the width of the ciliary body face. Journal of glaucoma 20020601
[Comparison of latanoprost monotherapy with timolol-dorzolamide combination in patients with open-angle glaucoma or ocular hypertension]. Journal francais d'ophtalmologie 20020601
The effects of new topical treatments on management of glaucoma in Scotland: an examination of ophthalmological health care. The British journal of ophthalmology 20020501
Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. American journal of ophthalmology 20020501
[Efficacy of latanoprost monotherapy treatment in primary open-angle glaucoma]. Archivos de la Sociedad Espanola de Oftalmologia 20020501
Effect of 0.005% latanoprost once daily on intraocular pressure in glaucomatous patients not adequately controlled by beta-blockers twice daily: a 3-year follow-up. Experience and incidence of side effects in a prospective study on 76 patients. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20020501
Intraocular pressure-lowering effects of latanoprost and brimonidine therapy in patients with open-angle glaucoma or ocular hypertension: a randomized observer-masked multicenter study. Journal of glaucoma 20020401
[Study on hypotensive effect of latanoprost vs timolol-dorzolamide association]. Archivos de la Sociedad Espanola de Oftalmologia 20020401
Bioavailability in the human eye of a fixed combination of latanoprost and timolol compared to monotherapy. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20020401
Effect of Xalatan(R) and Cosopt(R) on the vascular tone of quiescent isolated pig ciliary arteries. Klinische Monatsblatter fur Augenheilkunde 20020401
Metalloproteinase gene transcription in human ciliary muscle cells with latanoprost. Investigative ophthalmology & visual science 20020301
Expression of NADP+-dependent 15-hydroxyprostaglandin dehydrogenase mRNA in monkey ocular tissues and characterization of its recombinant enzyme. Journal of biochemistry 20020301
Allergic contact dermatitis to latanoprost. American journal of contact dermatitis : official journal of the American Contact Dermatitis Society 20020301
Prostaglandin analog treatment of glaucoma and ocular hypertension. The Annals of pharmacotherapy 20020301
Cystoid macular edema in the era of ocular hypotensive lipids. American journal of ophthalmology 20020301
Advances in topical glaucoma therapy. Veterinary ophthalmology 20020301
Effects of isopropyl unoprostone and latanoprost on melanogenesis in mouse epidermal melanocytes. Journal of glaucoma 20020201
Three-month comparison of brimonidine and latanoprost as adjunctive therapy in glaucoma and ocular hypertension patients uncontrolled on beta-blockers: tolerance and peak intraocular pressure lowering. Ophthalmology 20020201
HLA-DR expression in conjunctival cells after latanoprost. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20020201
Mechanism of vascular relaxation by cholinomimetic drugs with special reference to pilocarpine and arecoline. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20020201
The short-term effect of latanoprost on intraocular pressure and pulsatile ocular blood flow. Acta ophthalmologica Scandinavica 20020201
Pharmacological effects of latanoprost, prostaglandin E2, and F2alpha on isolated rabbit ciliary artery. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20020201
Latanoprost and brimonidine: therapeutic and physiologic assessment before and after oral nonsteroidal anti-inflammatory therapy. American journal of ophthalmology 20020101
Simple and inexpensive software designed for the evaluation of color. American journal of ophthalmology 20020101
Reduction of intraocular pressure in mouse eyes treated with latanoprost. Investigative ophthalmology & visual science 20020101
Latanoprost in hemifacial spasm. Prostaglandins & other lipid mediators 20020101
Additive effect of unoprostone and latanoprost in patients with elevated intraocular pressure. The British journal of ophthalmology 20020101
Pharmacological considerations in the treatment of glaucoma. Managed care (Langhorne, Pa.) 20020101
Comparison between isopropyl unoprostone and latanoprost by prostaglandin E(2)induction, affinity to prostaglandin transporter, and intraocular metabolism. Experimental eye research 20020101
Effects of isopropyl unoprostone, latanoprost, and prostaglandin E(2) on acute rise of aqueous flare in pigmented rabbits. Ophthalmic research 20020101
Effect of latanoprost on hair growth in the bald scalp of the stump-tailed macacque: a pilot study. Acta dermato-venereologica 20020101
Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension. Drugs & aging 20020101
Effect of topical ophthalmic latanoprost on intraocular pressure in normal horses. Veterinary therapeutics : research in applied veterinary medicine 20020101
Ocular surface changes induced by topical antiglaucoma monotherapy. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 20020101
Effect of latanoprost, prostaglandin F(2)alpha and nipradilol on isolated bovine ciliary muscle. Japanese journal of ophthalmology 20020101
Comparison of latanoprost, brimonidine and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with primary open-angle glaucoma and ocular hypertension. Acta ophthalmologica Scandinavica. Supplement 20020101
Eyelash hypertrichosis induced by topical latanoprost: 6-month follow-up study. Acta ophthalmologica Scandinavica. Supplement 20020101
Influence of latanoprost on the corneal epithelial barrier function in glaucoma patients. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 20020101
Ciliochoroidal effusion induced by topical latanoprost in a patient with sturge-weber syndrome. Japanese journal of ophthalmology 20020101
[Use of xalatan in unstable glaucoma in myopic patients]. Vestnik oftalmologii 20020101
A case of cystoid macular edema associated with latanoprost ophthalmic solution. Japanese journal of ophthalmology 20020101
Projected impact of travoprost versus both timolol and latanoprost on visual field deficit progression and costs among black glaucoma subjects. Transactions of the American Ophthalmological Society 20020101
Efficacy of latanoprost additive therapy on uncontrolled glaucoma. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 20020101
Efficacy of bimatoprost in glaucoma and ocular hypertension unresponsive to latanoprost. Advances in therapy 20020101
Cystoid macular edema in aphakia and pseudophakia after use of prostaglandin analogs. Seminars in ophthalmology 20020101
Predictive value of a 1-day, 1-eye trial on the 1-month ocular hypotensive response of latanoprost 0.005%. American journal of ophthalmology 20011201
Choroidal detachment after the use of topical latanoprost. American journal of ophthalmology 20011201
Corneal effects of latanoprost and timolol. Ophthalmology 20011201
A comparison of intraocular pressure-lowering effect of prostaglandin F2 -alpha analogues, latanoprost, and unoprostone isopropyl. Journal of glaucoma 20011201
Effects of topical administration of 0.005% latanoprost solution on eyes of clinically normal horses. American journal of veterinary research 20011201
The latanoprost monotherapy survey in New Zealand, 2000. Clinical & experimental ophthalmology 20011201
Intraocular pressure over 24 hours after single-dose administration of latanoprost 0.005% in healthy volunteers. A randomized, double-masked, placebo controlled, cross-over single center study. Acta ophthalmologica Scandinavica 20011201
A comparison of the efficacy and tolerability of brimonidine and latanoprost in adults with open-angle glaucoma or ocular hypertension: a three-month, multicenter, randomized, double-masked, parallel-group trial. Clinical therapeutics 20011201
Effect of different dose schedules of latanoprost on intraocular pressure and pupil size in the glaucomatous Beagle. Veterinary ophthalmology 20011201
Effects of topical latanoprost on optic nerve head circulation in rabbits, monkeys, and humans. Investigative ophthalmology & visual science 20011101
Preoperative latanoprost to prevent ocular hypertension after phacoemulsification and intraocular lens implantation. Journal of cataract and refractive surgery 20011101
Ocular surface changes induced by topical application of latanoprost and timolol: a short-term study in glaucomatous patients with and without allergic conjunctivitis. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20011101
Contribution of lymphatic drainage system in corneal allograft rejection in mice. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20011101
Drug points. Exacerbation of angina associated with latanoprost. BMJ (Clinical research ed.) 20011006
The effect on intraocular pressure of latanoprost once or four times daily. The British journal of ophthalmology 20011001
Enhanced FGF-2 movement through human sclera after exposure to latanoprost. Investigative ophthalmology & visual science 20011001
Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. American journal of ophthalmology 20011001
Effects of latanoprost and unoprostone when used alone or in combination for open-angle glaucoma. American journal of ophthalmology 20011001
Choroidal detachment following extracapsular cataract extraction in a patient treated with latanoprost. The British journal of ophthalmology 20011001
Effect of temperature and light on the stability of latanoprost and its clinical relevance. Journal of glaucoma 20011001
Iridial pigmentation induced by latanoprost ophthalmic solution in Japanese glaucoma patients. Journal of glaucoma 20011001
Latanoprost-induced iris heterochromia and open-angle glaucoma: a clinicopathologic report. Journal of glaucoma 20011001
Topical latanoprost and optic nerve head and retinal circulation in humans. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20011001
Additive efficacy of unoprostone isopropyl 0.12% (rescula) to latanoprost 0.005%. American journal of ophthalmology 20010901
Additive efficacy of unoprostone isopropyl 0.12% (rescula) to latanoprost 0.005%. American journal of ophthalmology 20010901
Latanoprost and cystoid macular edema in high-risk aphakic or pseudophakic eyes. Journal of cataract and refractive surgery 20010901
[The pH reaction in aqueous humor to antiglaucoma agents of various concentrations and pH levels]. Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti 20010901
Meta-analysis of randomised controlled trials comparing latanoprost with timolol in the treatment of patients with open angle glaucoma or ocular hypertension. The British journal of ophthalmology 20010801
Intraocular pressure over 24 hours after repeated administration of latanoprost 0.005% or timolol gel-forming solution 0.5% in patients with ocular hypertension. Ophthalmology 20010801
Herpes simplex dendritic keratitis after treatment with latanoprost for primary open angle glaucoma. The British journal of ophthalmology 20010801
Intermittent blurred vision and trichomegaly due to latanoprost. Clinical & experimental ophthalmology 20010801
Comparison of the additive intraocular pressure-lowering effect of latanoprost and dorzolamide when added to timolol in patients with open-angle glaucoma or ocular hypertension: a randomized, open-label, multicenter study in Greece. Journal of glaucoma 20010801
Reliable measurement of mouse intraocular pressure by a servo-null micropipette system. Investigative ophthalmology & visual science 20010701
Herpes simplex virus dermatitis in patients using latanoprost. American journal of ophthalmology 20010701
[Change in the pH of aqueous humor after administration of anti-glaucoma agents in rabbits in vivo]. Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti 20010701
[Additive effects of topical carbonic anhydrase inhibitors]. Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti 20010701
Potential mechanism for the additivity of pilocarpine and latanoprost. American journal of ophthalmology 20010601
Washout periods for brimonidine 0.2% and latanoprost 0.005%. American journal of ophthalmology 20010601
Additive IOP-reducing effect of latanoprost in patients insufficiently controlled on timolol. Acta ophthalmologica Scandinavica 20010601
Induction of tyrosinase gene transcription in human iris organ cultures exposed to latanoprost. Archives of ophthalmology (Chicago, Ill. : 1960) 20010601
Effect of pilocarpine 4% in combination with latanoprost 0.005% or 8-iso prostaglandin E2 0.1% on intraocular pressure in laser-induced glaucomatous monkey eyes. Journal of glaucoma 20010601
Effectiveness and safety of brimonidine as adjunctive therapy for patients with elevated intraocular pressure in a large, open-label community trial. Journal of glaucoma 20010601
Cystoid macular edema associated with topical latanoprost in glaucomatous eyes with a normally functioning blood-ocular barrier. Journal of glaucoma 20010601
[Effect of latanoprost on ocular hemodynamics and contrast sensitivity]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 20010601
Bilateral poliosis and granulomatous anterior uveitis associated with latanoprost use and apparent hypotrichosis on its withdrawal. Eye (London, England) 20010601
From PGF(2alpha)-isopropyl ester to latanoprost: a review of the development of xalatan: the Proctor Lecture. Investigative ophthalmology & visual science 20010501
The efficacy and safety of latanoprost 0.005% once daily versus brimonidine 0.2% twice daily in open-angle glaucoma or ocular hypertension. American journal of ophthalmology 20010501
A randomized double-masked crossover study comparing latanoprost 0.005% with unoprostone 0.12% in patients with primary open-angle glaucoma and ocular hypertension. American journal of ophthalmology 20010501
Effects of topical unoprostone and latanoprost on acute and recurrent herpetic keratitis in the rabbit. American journal of ophthalmology 20010501
Case reports and small case series: LASIK-associated visual field loss in a glaucoma suspect. Archives of ophthalmology (Chicago, Ill. : 1960) 20010501
[Recurrent corneal keratitis associated with the use of latanoprost]. Archivos de la Sociedad Espanola de Oftalmologia 20010501
Effect of intracameral acetylcholine on latanoprost in preventing ocular hypertension after phacoemulsification and intraocular lens implantation. Journal of cataract and refractive surgery 20010501
Intraindividual comparison of the effects of a fixed dorzolamide-timolol combination and latanoprost on intraocular pressure after small incision cataract surgery. Journal of cataract and refractive surgery 20010501
[Increased iris pigmentation after use of latanoprost in Japanese brown eyes]. Nippon Ganka Gakkai zasshi 20010501
[Effect of latanoprost on the barrier function of corneal epithelium]. Nippon Ganka Gakkai zasshi 20010501
Latanoprost is a vasoconstrictor in isolated porcine ciliary arteries. Klinische Monatsblatter fur Augenheilkunde 20010501
Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: a 30-day comparison with latanoprost. Survey of ophthalmology 20010501
Update on topical carbonic anhydrase inhibitors. Current opinion in ophthalmology 20010401
The pros and cons of different prostanoids in the medical management of glaucoma. Current opinion in ophthalmology 20010401
Hypertrichosis induced by latanoprost. Journal of the American Academy of Dermatology 20010401
Latanoprost exerts neuroprotective activity in vitro and in vivo. Experimental eye research 20010401
Therapeutic potential of prostaglandin analogues in glaucoma. Expert opinion on investigational drugs 20010401
Bimatoprost: a member of a new class of agents, the prostamides, for glaucoma management. Expert opinion on investigational drugs 20010401
The effect on diurnal intraocular pressure of the fixed combination of latanoprost 0.005% and timolol 0.5% in patients with ocular hypertension. Acta ophthalmologica Scandinavica 20010401
Latanoprost and periocular skin color changes. Archives of ophthalmology (Chicago, Ill. : 1960) 20010401
Effect on intraocular pressure during 24 hours after repeated administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in patients with ocular hypertension. Journal of glaucoma 20010401
Ocular complications of latanoprost in uveitic glaucoma: three case reports. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20010401
[Effects of topical prostaglandin analogues on the aqueous flare intensity in rabbit eyes at an early phase of endotoxin-induced uveitis]. Nippon Ganka Gakkai zasshi 20010401
Effect of latanoprost and timolol on the histopathology of the rabbit conjunctiva. Investigative ophthalmology & visual science 20010301
Additive efficacy of unoprostone isopropyl 0.12% (rescula) to latanoprost 0.005%. American journal of ophthalmology 20010301
[Juvenile glaucoma: a 17-year-old patient with liver transplantation]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 20010301
Latanoprost and matrix metalloproteinase-1 in human choroid organ cultures. Current eye research 20010301
A double-masked, randomized clinical trial comparing latanoprost with unoprostone in patients with open-angle glaucoma or ocular hypertension. Ophthalmology 20010201
Comparison of the corneal effects of latanoprost, fixed combination latanoprost-timolol, and timolol: A double-masked, randomized, one-year study. Ophthalmology 20010201
Latanoprost versus combined therapy with timolol plus dorzolamide: IOP-lowering effect in open-angle glaucoma. Acta ophthalmologica Scandinavica 20010201
Histological effects in the iris after 3 months of latanoprost therapy: the Mainz 1 study. Archives of ophthalmology (Chicago, Ill. : 1960) 20010201
Migraine headache associated with latanoprost. Archives of ophthalmology (Chicago, Ill. : 1960) 20010201
Acute effect of latanoprost on pulsatile ocular blood flow in normal eyes. American journal of ophthalmology 20010201
Eyelash hypertrichosis in a patient treated with topical latanoprost. Cutis 20010201
Ockham's glaucoma. Clinical & experimental ophthalmology 20010201
Twenty-four hour intraocular pressure reduction with latanoprost compared with pilocarpine as third-line therapy in exfoliation glaucoma. Eye (London, England) 20010201
Intraocular pressure-lowering efficacy of latanoprost in patients with normal-tension glaucoma or primary open-angle glaucoma. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20010201
Short-time application of latanoprost does not stimulate melanogenesis in bovine ocular melanin-containing cells in vitro. Ophthalmic research 20010101
Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension. Advances in therapy 20010101
Enhancement of scleral macromolecular permeability with prostaglandins. Transactions of the American Ophthalmological Society 20010101
Eyelid hypertrichosis associated with latanoprost is reversible. European journal of ophthalmology 20010101
[Pharmacodynamics and pharmacokinetics of prostaglandins and their derivates in eye tissues]. Klinika oczna 20010101
[Non surgical alternatives in the treatment of the primitive open angle glaucoma]. Oftalmologia (Bucharest, Romania : 1990) 20010101
Does glaucoma medication influence the diameter of the retinal arteriole in the human eye? (A pilot study using the retinal vessel analyser). Acta physiologica Hungarica 20010101
Choroidal effusion and shallowing of the anterior chamber after adjunctive therapy with latanoprost in a trabeculectomized patient with angle closure glaucoma. International ophthalmology 20010101
Microvascular effects of selective prostaglandin analogues in the eye with special reference to latanoprost and glaucoma treatment. Progress in retinal and eye research 20000701
The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochimica et biophysica acta 20000117
A randomized, comparative open-label study on the efficacy of latanoprost and timolol in steroid induced ocular hypertension after photorefractive keratectomy. European journal of ophthalmology 20000101
Comparison of the effect of latanoprost 0.005% and timolol 0.5% on the calculated ocular perfusion pressure in patients with normal-tension glaucoma. American journal of ophthalmology 19980501
Effects of latanoprost and dipivefrin, alone or combined, on intraocular pressure and on blood-aqueous barrier permeability. The British journal of ophthalmology 19980401
Additive ocular hypotensive effect of latanoprost and acetazolamide. A short-term study in patients with elevated intraocular pressure. Ophthalmology 19970901
The lack of respiratory effects of the ocular hypotensive drug latanoprost in patients with moderate-steroid treated asthma. Survey of ophthalmology 19970201
A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study. Archives of ophthalmology (Chicago, Ill. : 1960) 19960801
Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group. Ophthalmology 19960101
Additive effect of latanoprost, a prostaglandin F2 alpha analogue, and timolol in patients with elevated intraocular pressure. The British journal of ophthalmology 19941201
Interaction of PhXA41, a new prostaglandin analogue, with pilocarpine. A study on patients with elevated intraocular pressure. Archives of ophthalmology (Chicago, Ill. : 1960) 19930501

© 2019 Angene International Limited. All rights Reserved.